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Abstract 1 
The c-Jun N-terminal kinase (JNK) signal transduction pathway is implicated in learning and 2 
memory.  Here, we examined the role of JNK activation mediated by the JIP1 scaffold protein.  3 
We compared male wild-type mice with a mouse model harboring a point mutation in the Jip1 4 
gene that selectively blocks JIP1-mediated JNK activation.  These male mutant mice exhibited 5 
increased NMDA receptor currents, increased NMDA receptor-mediated gene expression, and 6 
a lower threshold for induction of hippocampal long-term potentiation.  The JIP1 mutant mice 7 
also displayed improved hippocampus-dependent spatial memory and enhanced associative 8 
fear conditioning.  These results were confirmed using a second JIP1 mutant mouse model that 9 
suppresses JNK activity.  Together, these observations establish that JIP1-mediated JNK 10 
activation contributes to the regulation of hippocampus-dependent, NMDA receptor-mediated 11 
synaptic plasticity and learning.  12 
 13 
Significance Statement 14 
The results of this study demonstrate that JNK activation induced by the JIP1 scaffold protein 15 
negatively regulates the threshold for induction of long-term synaptic plasticity through the 16 
NMDA-type glutamate receptor. This change in plasticity threshold influences learning.  Indeed, 17 
mice with defects in JIP1-mediated JNK activation display enhanced memory in hippocampus-18 
dependent tasks, such as contextual fear conditioning and Morris water maze, indicating that 19 
JIP1-JNK constrains spatial memory. This study reports the identification of JIP1-mediated JNK 20 
activation as a novel molecular pathway that negatively regulates NMDA receptor-dependent 21 
synaptic plasticity and memory.  22 
23 
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Introduction 24 
Human genetic studies have demonstrated that mutations in genes underlying the cJun NH2-25 
terminal kinase (JNK) signaling pathway are associated with neuropsychiatric, neurological and 26 
neurodevelopmental disorders, including schizophrenia (MAP2K7) (Winchester et al., 2012), 27 
epilepsy (MAPK10) (Shoichet et al., 2006), autism spectrum disorder (MAPK8IP2 & TAOK2) 28 
(Weiss et al., 2008; Giza et al., 2010; de Anda et al., 2012), and learning disability (MAPK10) 29 
(Baptista et al., 2008; Kunde et al., 2013).  These observations suggest that the JNK pathway 30 
has an important normal function in the central nervous system (CNS).  Indeed, recent studies 31 
using C. elegans (Inoue et al., 2013) and murine (Sherrin et al., 2011) experimental models 32 
showed that JNK-deficiency results in enhanced memory.  This is exemplified by the 33 
observations that JNK1-deficient mice exhibit enhanced associative learning, including 34 
contextual fear conditioning (Sherrin et al., 2010) and altered synaptic plasticity (Li et al., 2007).  35 
Complementary studies using pharmacological inhibition of JNK demonstrate increased long-36 
term depression (LTD) and loss of depotentiation (Yang et al., 2011).  Moreover, JNK activation 37 
has been implicated in stress-mediated inhibition of long-term potentiation (LTP) (Curran et al., 38 
2003; Wang et al., 2004).  Mechanisms that contribute to JNK-regulated synaptic plasticity 39 
include NMDA receptor-stimulated JNK activation (Mukherjee et al., 1999), AMPA receptor 40 
internalization (Zhu et al., 2005), and synaptic recruitment of PSD95 (Kim et al., 2007).  41 
Collectively, these data indicate that JNK plays a key role in the regulation of synaptic plasticity.   42 
 Although progress towards understanding the role of JNK in neuronal signaling has been 43 
achieved, little is known about the mechanisms that regulate JNK during behavioral responses.  44 
Previous studies have implicated roles for scaffold proteins in the control of MAP kinase 45 
signaling cascades, including the JNK signaling pathway (Morrison and Davis, 2003).  Indeed, 46 
the JNK-interacting protein 1 (JIP1) scaffold protein can assemble a functional JNK signaling 47 
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pathway (Whitmarsh et al., 1998; Whitmarsh et al., 2001).  JIP1 is required for JNK activation 48 
caused by specific stimuli, including metabolic and excitotoxic stress (Whitmarsh et al., 2001; 49 
Morel et al., 2010).  However, JIP1 is not required for JNK activation caused by other stimuli, 50 
including inflammatory cytokines (Whitmarsh et al., 2001).   51 
JIP1 is highly expressed in the brain (Dickens et al., 1997; Whitmarsh et al., 1998) and 52 
localizes to synapses (Pellet et al., 2000).  Interestingly, mice with JIP1-deficiency exhibit 53 
increased NMDA receptor signaling (Kennedy et al., 2007), implicating JIP1-mediated JNK 54 
activation in the regulation of NMDA receptor activity.  The purpose of this study was to examine 55 
the impact of JIP1-regulated JNK activation on neuronal function and behavior.  JIP1 may 56 
contribute to multiple biological processes, including microtubule motor protein function and JNK 57 
signaling (Morrison and Davis, 2003).  The interpretation of studies using JIP1 knockout mice 58 
(Whitmarsh et al., 2001) is therefore complicated by the presence of defects in JIP1-mediated 59 
JNK activation and defects in other JIP1-mediated biochemical activities.  Consequently, we 60 
examined the effect of a point mutation in JIP1 (Thr103Ala) that selectively prevents JIP1-61 
mediated JNK activation (Morel et al., 2010).  This block in JNK activation is accounted for by a 62 
required role of JIP1 phosphorylation on Thr103 for dynamic association with upstream MAP3K 63 
components of the signaling cascade (Nihalani et al., 2003; Morel et al., 2010). Our results 64 
demonstrated that JIP1-mediated JNK activation regulates hippocampus-dependent, NMDA 65 
receptor-linked synaptic plasticity and memory. This conclusion was confirmed using a second 66 
mouse model with point mutations that disrupt the JNK binding site on JIP1, which also prevents 67 
JIP1-mediated JNK activation and alters hippocampus-dependent learning. Collectively, the 68 
data demonstrate that the JIP1-JNK signaling axis negatively regulates synaptic plasticity and 69 
spatial memory, possibly functioning to constrain and/or shape learning and memory under 70 
specific contexts.  71 
 72 
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Materials and Methods 73 
 74 
Mice 75 
C57BL/6J mice (stock number 000664) were obtained from the Jackson Laboratory and were 76 
estsablished as a colony in our facility.  The Jip1 Thr103Ala (JIP1TA) mice have been described 77 
previously (Morel et al., 2010).  Mice with a defect in the JNK binding domain of JIP1 78 
(replacement of Leu160-Asn161-Leu162 with Gly160-Arg161-Gly162) were established by homologous 79 
recombination in embryonic stem (ES) cells using standard methods.  The mutated allele is 80 
designated as Jip1∆JBD.  Briefly, a targeting vector was constructed that was designed to 81 
introduce point mutations in exon 3 of the Jip1 gene to create the ∆JBD mutation.  TC1 82 
embryonic stem cells (strain129svev) (RRID:CVCL_M350) were electroporated with this vector 83 
and selected with 200 μg/ml G418 (Thermo Fisher Scientific, Cat# 10131035) and 2 μM 84 
ganciclovir (Millipore, Cat# 345700).  ES cell clones without (genotype +/NeoR-Jip1WT) and with 85 
(genotype +/NeoR-Jip1∆JBD) the ∆JBD mutation in exon 3 were identified.  These ES cells were 86 
injected into C57BL/6J blastocysts to create chimeric mice that were bred to obtain germ-line 87 
transmission of the targeted Jip1 allele. The floxed NeoR cassette was excised using Cre 88 
recombinase.  The full characterization of these mice has been described elsewhere (Kant et 89 
al., 2017).  All mice used in this study were backcrossed (ten generations) to the C57BL/6J 90 
strain (Jackson Laboratories).  All studies were performed using male mice.  The mice were 91 
housed in a facility accredited by the American Association for Laboratory Animal Care 92 
(AALAC). The Institutional Animal Care and Use Committee (IACUC) of the University of 93 
Massachusetts, University of Hawaii, and Morehouse School of Medicine approved all studies 94 
using animals. 95 
 96 
Primary hippocampal neurons 97 
Embryonic day 16.5 mouse embryos were used for isolation of primary hippocampal neurons 98 
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(Whitmarsh et al., 2001).  Briefly, hippocampi were placed in ice-cold Hank’s buffered saline 99 
solution containing 20 mM HEPES (pH 7.3; HBSS, Thermo Fisher Scientific, Cat# 15630080) 100 
and digested with 1% Trypsin (Thermo Fisher Scientific, Cat# 17075029) in the presence of 1 101 
mg/mL DNase I (Sigma, Cat# 11284932001). The trypsin solution was removed, and the 102 
minced tissue was triturated in 1.0 mL of HBSS-20mM HEPES containing DNase I (1 mg/mL) 103 
(Sigma, Cat# 11284932001) and soybean trypsin inhibitor (0.5 mg/mL) (Thermo Fisher 104 
Scientific, Cat# 17075029) to obtain a single-cell suspension.  Dissociated neurons were 105 
centrifuged (180g, 10 min, 4°C) through a cushion of 4% bovine serum albumin (BSA) (Thermo 106 
Fisher Scientific, Cat# B14) in HBSS.  Hippocampal neurons were seeded in poly-D-107 
lysine/laminin-coated chamber slides (BD Biosciences, Cat# 354687) in Neurobasal medium 108 
(Thermo Fisher Scientific, Cat# 21103049) containing B27 supplement (Thermo Fisher 109 
Scientific, Cat# 17504044), 1% glutamine (Thermo Fisher Scientific, Cat# 21051024), and 1% 110 
penicillin/streptomycin (Thermo Fisher Scientific, Cat# 15140122).   111 
 Gene expression studies were performed using hippocampal neurons cultured for 14 112 
days in vitro (14DIV).  The neurons were treated without or with 100 μM NMDA/10 μM Glycine 113 
(Sigma, Cat# M3262, Cat# G5417) in complete Neurobasal media (Thermo Fisher Scientific, 114 
Cat# 21103049).  The expression of mRNA was measured by quantitative RT-PCR assays. 115 
Immunofluorescence analysis was performed using hippocampal neurons cultured for 16 116 
days in vitro (16DIV).  Two different procedures were used to prepare neurons for 117 
immunofluorescence analysis.  First, permeabilized fixed neurons were prepared by incubation 118 
with 4% (w/v) paraformaldehyde (Thermo Fisher Scientific, Cat# 28906) at room temperature 119 
(20 min) followed by incubation with 0.1% Triton X-100 in PBS (5 min) (Thermo Fisher 120 
Scientific, Cat# 85112), and then blocking buffer (1% BSA (Thermo Fisher Scientific, Cat# B14), 121 
2% normal goat serum (Thermo Fisher Scientific, Cat# 31872), in PBS) for 1 h.  Second, non-122 
permeabilized fixed neurons were prepared by incubation with 4% (w/v) paraformaldehyde / 4% 123 
(w/v) sucrose (Thermo Fisher Scientific, Cat# 28906, Fisher Scientific, Cat# BP-2201) at room 124 
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temperature (8 min) followed by incubation (1 h) in blocking buffer.  Neurons prepared by both 125 
methods were incubated overnight with primary antibodies to GluN1 (1:100, Millipore, Cat# 05-126 
432, RRID: AB_390129) and ?-Tubulin (1:500), Covance Research Products Inc, Cat# PRB-127 
433C-200, RRID: AB_291636) in blocking buffer and then washed.  The primary antibodies 128 
were detected by incubation with anti-mouse or anti-rabbit Ig conjugated to Alexa Fluor 488 or 129 
633 (1:200, Molecular Probes, Cat# A-11094, RRID: AB_221544; Thermo Fisher Scientific, 130 
Cat# A21100, RRID: AB_10374307).  DNA was detected by staining with DAPI (Vectashield 131 
with DAPI, Vector Laboratories, Cat# H-1200).  Fluorescence was visualized using a Leica TCS 132 
SP2 confocal microscope equipped with a 405-nm diode laser.  The mean fluorescence 133 
intensity was quantitated using ImageJ software (RRID:SCR_001775). 134 
 135 
Preparation of synaptosomes 136 
Hippocampi from 4 mice (age 8-12 weeks) were isolated and homogenized in Syn-PER buffer 137 
(Thermo Fisher Scientific, Cat# 87793).  Briefly, neuronal tissue was homogenized in Syn-PER 138 
reagent, centrifuged following manufacturer’s instruction, followed by suspension of the resulting 139 
synaptosome pellet in Syn-PER reagent to yield 3-4μg/μl of synaptic protein. The synaptosomes 140 
contain the complete presynaptic terminal, including mitochondria and synaptic vesicles, and 141 
also the postsynaptic membrane and the postsynaptic density (Villasana et al., 2006).  142 
 143 
RNA analysis 144 
The expression of mRNA was examined by quantitative RT-PCR analysis using a 7500 Fast 145 
real-time PCR machine.  Taqman® assays were used to quantitate cFos (Mm00487425_m1), 146 
cJun (Mm00495062_s1), Bdnf (Mm00432069_m1), GluN1 (Grin1, Mm00433800_m1), GluN2A 147 
(Grin2a, Mm00433802_m1) and GluN2B (Grin2b, Mm00433820_m1) (Thermo Fisher 148 
Scientific).  The relative mRNA expression was normalized by measurement of Gapdh 149 
(4352339E-0904021; Thermo Fisher Scientific) in each sample using Taqman® assays.   150 
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 151 
 152 
Immunoblot analysis 153 
Tissue extracts were prepared from snap-frozen brain regions from JIP1WT and JIP1TA adult 154 
mice (8-12 week-old) using Triton lysis buffer (20 mM Tris-pH 7.4, 1% Triton-X100, 10% 155 
glycerol, 137 mM NaCl, 2 mM EDTA, 25 mM ?-glycerophosphate, 1 ?M sodium orthovanadate, 156 
1 ?M PMSF, 10 ?g/mL Leupeptin, and 10 ?g/mL Aprotinin).  Extracts (20-50 μg of protein) were 157 
examined by protein immunoblot analysis by probing with antibodies to pSer63-cJun (1:1000, 158 
Cell Signaling Technologies Cat# 2361, RRID: AB_490908), JNK (1:1000, Cell Signaling 159 
Technologies Cat# 9252, RRID: AB_2250373), GAPDH (Cell Signaling Technologies Cat# 160 
2118, RRID: AB_561053, GluN2B (1:1000, Cell Signaling Technologies Cat#4212S, RRID: 161 
AB_2112463), SAP102 (1:1000, Cell Signaling Technologies Cat# 3730S, RRID: AB_2092180), 162 
pERK1/2 (1:1000, Cell Signaling Technologies Cat# 5683P, RRID: AB_10841299), pSer133 163 
CREB (1:1000, Cell Signaling Technologies Cat# 9198, RRID: AB_2561044) and CREB 164 
(1:1000, Cell Signaling Technologies Cat#9197, RRID: AB_321277), ERK2 (1:1000, Santa Cruz 165 
Biotechnology Cat# sc-81457, RRID: AB_1122619), JNK1/2 ( Santa Cruz Biotechnology Cat# 166 
sc-137019, RRID: AB_2140722), pJNK (Santa Cruz Biotechnology Cat# sc-6254, RRID: 167 
AB_628232) and GluN2A (1:500, Millipore Cat# 07-632, RRID: AB_310837), pY1472 GluN2B 168 
(1:1000, Millipore Cat# AB5403, RRID: AB_11210694; GluN1 (Millipore Cat# 05-432, RRID: 169 
AB390129), GluA1 (1:2000, Millipore Cat# 04-855, RRID: AB_1977216), GluA2 (1:1000, 170 
Millipore Cat# 07-261, RRID: AB_2116167), Synapsin I (1:1000, Millipore Cat# AB 1543, RRID: 171 
AB_11210367), ??-Tubulin (1:5000, Covance Research Products Inc Cat# PRB-435P-100, 172 
RRID: AB_291637), PSD-95 (1:2000, Sigma-Aldrich Cat# P246, RRID: AB_260911) and KIF17 173 
(1:1000, Sigma-Aldrich Cat# K3638, RRID: AB_477148).  Immunocomplexes were detected by 174 
fluorescence using anti-mouse (1:5000, LI-COR Biosciences Cat# 926-32210, RRID: 175 
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AB_621842) and anti-rabbit secondary IRDye antibodies, (1:5000, LI-COR Biosciences Cat# 176 
827-08365, RRID: 10796098) and quantitated using a LI-COR Imaging system. 177 
 178 
Multiplexed ELISA 179 
Quantitative analysis of pSer63-cJun (Bio-Rad, Cat#171-V50003M), cJun (Bio-Rad, Cat#171-180 
V60002M), pJNK (Bio-Rad, Cat#171-V50011M), JNK (Bio-Rad, Cat#171-V60007M), pERK 181 
(Bio-Rad, Cat#171-V50006M) and ERK1/2 (Bio-Rad, Cat#171-V60003M) was performed using 182 
Bio-Plex Pro Cell Signaling Reagent kit (Bio-Rad, Cat#171-304006M) and a Luminex 200 183 
instrument (Millipore-Sigma). 184 
 185 
Kainate-induced excitotoxicity 186 
JIP1WT and JIP1TA mice (8-12 week-old) were injected intraperitoneally with 30 mg/kg kainic acid 187 
(Tocris, Cat# 0222) (Yang et al., 1997).  At 2h post-treatment, the mice were perfused with 4% 188 
paraformaldehyde.  Brains were harvested and fixed for an additional 24h in 4% 189 
paraformaldehyde, then dehydrated and embedded in paraffin.  Coronal sections (5 μm) were 190 
cut, rehydrated and subjected to heat-induced antigen retrieval (Vector Laboratories, cat# H-191 
3301).  Sections were blocked for 1h at room temperature (1% BSA, 2% normal goat serum, 192 
0.4% Triton-X100 in PBS) and incubated overnight with primary antibodies to pSer63-cJun 193 
(1:100, Cell Signaling Technologies Cat# 2361, RRID: AB_490908), or cFos (1:200, Cell 194 
Signaling Technologies Cat# 4384S, RRID: AB_10698737) or cJun (1:100, Santa Cruz 195 
Biotechnology Biotechnology Cat# sc-1694, RRID:AB_631263).  The primary antibodies were 196 
detected by incubation with anti-rabbit Ig conjugated to Alexa Fluor 488 (1:200, Thermo Fisher 197 
Scientific Cat# A11008, RRID: AB_143165).  DNA was detected by staining with DAPI 198 
(Vectashield with DAPI, Vector Laboratories, Cat# H-1200).  Fluorescence was visualized using 199 
a Leica TCS SP2 confocal microscope equipped with a 405-nm diode laser. 200 
  
?
10 
??? ?
 201 
Surgery and infusions 202 
Mice were anesthetized with 1.2% Avertin (2, 2, 2-Tribromoethanol, Sigma-Aldrich, #T4, 840-2, 203 
15.5 ml tert-amyl alcohol (2-methyl-2-butanol), Fisher, #A730-1) and implanted bilaterally with 204 
26 gauge guide cannulae (Plastics One) into the dorsal hippocampus (anteroposterior (AP) - 0.5 205 
mm, lateral 1 mm, depth 1.3 mm). Mice were allowed to recover for at least 7 days prior to 206 
behavioral experiments. Intrahippocampal infusions were made using custom 28 gauge 207 
injectors (Plastics One, Cat# C232I/SPC) that extended 1 mm beyond the tips of the guide 208 
cannulae. On the day of the experiment, bilateral injections were performed using an infusion 209 
pump (CMA/100, CMA/Microdialysis) at a constant rate of 0.5 μl/min (final volume: 0.25 μl/side).  210 
The competitive NMDA receptor antagonist, D,L-2-amino-5-phosphonovaleric acid (APV; 10 211 
μg/ml; Sigma, Cat# A5282), was dissolved in artificial cerebrospinal fluid (aCSF) (130 mM NaCl, 212 
3.5 mM KCl, 10 mM glucose, 1.25 mM NaH2PO4, 2.0 mM CaCl2, 1.5 mM MgSO4 and 24 mM 213 
NaHCO3). Controls received equal volumes of aCSF infused at the same rate.  All infusions 214 
were made 15 minutes before contextual fear conditioning. 215 
 216 
Analysis of dendritic spine density and morphology 217 
Golgi staining was performed using the FD Rapid Golgi Stain Kit (FD Neurotechnologies, Cat# 218 
PK401) following the manufacturer’s guidelines.  Coronal sections (150 μm) were obtained 219 
using a microtome (Leica VT1000S).  Spines examined were apical (stratum radiatum) and 220 
basal (stratum oriens) dendrites of CA1 pyramidal neurons.  CA1 pyramidal neurons were 221 
traced using a Zeiss Axioskop 2 Plus microscope with a 100x oil immersion objective.  Only 222 
pyramidal neurons that exhibited complete impregnation and not obscured by other neurons or 223 
artifacts were examined.  Five neurons per animal were three-dimensionally reconstructed using 224 
NeuroLucida Software (MicroBrightField) (RRID:SCR_001775).  At least three apical (>50 μm 225 
from soma) and three basal (>30 μm from soma) dendritic segments (>25 μm length) were 226 
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quantified in each neuron.  Spine densities were calculated as mean numbers of spines per 10 227 
μm per dendrite per neuron in individual mice.  Dendritic arborization was carried out using a 228 
Sholl analysis of the apical and basilar dendrites of these neurons.  Briefly, a series of 229 
increasingly large concentric circles centered at the cell body and separated by 10 μm radius 230 
intervals were superimposed upon traces of apical and basilar dendrites; the number of 231 
dendritic intersections with each concentric circle was recorded.  On the basis of morphology, 232 
spines were classified into the following categories: thin, mushroom, and stubby (Korobova and 233 
Svitkina, 2010). 234 
 235 
Analysis of tissue sections 236 
Paraformaldehyde-fixed brains were cryoprotected in 30% sucrose in 0.1 M PBS for 48 h at 237 
4°C.  Immunohistochemical analysis was performed on free-floating sections cut at 30 μm on a 238 
cryostat. The sections were washed once with PBS and blocked with 5% goat serum (Vector 239 
Laboratories, Cat# S-1000) in PBST (PBS + 0.3% Triton X-100) for 1 h.  The sections were then 240 
incubated overnight with primary antibodies to JIP1 (1:500, BD Biosciences, Cat# 611890, 241 
RRID: AB_399370), anti-NeuN antibody (1:500, Millipore, Cat# MAB377, RRID: AB_2298772), 242 
MAP2 antibody (1: 500, Millipore, Cat# AB5622, RRID: AB_91939), GAD67 antibody (1: 5000, 243 
Millipore, Cat# MAB5406 RRID: AB_2278725), or GFAP antibody (1:150, Promega, Cat# 244 
G5601, RRID:AB_430855) at 4°C.  The sections were washed in PBST and incubated (1h) with 245 
anti-mouse Ig or anti-rabbit Ig conjugated to Alexa Fluor 488 (Thermo Fisher Scientific Cat# 246 
S11223 RRID: AB_2336881) or 546 (Thermo Fisher Scientific Cat# S11225 RRID: 247 
AB_2532130).  Nuclei were stained using DAPI (Vectashield with DAPI, Vector Laboratories, 248 
Cat# H-1200).  Images were obtained with a Zeiss Axio Imager 2 microscope at 10X and 20X 249 
magnification.  The mean fluorescence intensity was quantitated using ImageJ (RRID: 250 
SCR_003070) software. Sections were also examined using Nissl stain (Thermo Fisher 251 
Scientific, Cat# N21479).  252 
  
?
12 
??? ?
 253 
Fear conditioning and extinction 254 
Context-dependent and tone-dependent fear conditioning were performed using a computer-255 
controlled fear conditioning system (TSE, Bad Homburg, Germany) (Todorovic et al., 2007).  256 
The fear conditioning was performed in a Plexiglas cage (36 x 21 x 20 cm) within a fear 257 
conditioning box.  The training (conditioning) consisted of a single trial. The mouse was exposed 258 
to the conditioning context (180 s), followed by a tone [conditioned stimulus (CS), 30 s, 10 kHz, 259 
75 dB SPL, pulsed 5 Hz]. After termination of the tone, a foot shock [unconditioned stimulus 260 
(US), 0.8 mA or 0.4 mA, 2 s, constant current] was delivered through a stainless steel grid floor. 261 
Under these conditions, the context served as background stimulus. Background contextual fear 262 
conditioning but not foreground contextual fear conditioning, in which the tone is omitted during 263 
training, has been shown to involve the hippocampus (Phillips and LeDoux, 1992). A 264 
loudspeaker provided constant background noise.  Contextual memory was tested in the fear-265 
conditioning box for 180 s without CS or US presentation (with background noise), 24 h after 266 
contextual fear conditioning. The context-dependent extinction trials were performed at 24 h 267 
intervals and consisted of non-reinforced, 3-min exposures (absence of a foot shock) to the 268 
same context. For fear response extinction, the aforementioned protocol was used to acquire 269 
contextual fear memory. Tone-dependent memory test was performed in a novel context 270 
(context 2), 24 h after cued fear conditioning. Context 2 represented an identically sized cage 271 
with a plain floor in a light-surrounding environment (350-500 lux) outside the fear-conditioning 272 
box. No background noise was provided in context 2. During tone-dependent memory test, a 273 
180-s pause without stimulation (pre-CS phase) preceded a 180-s period of auditory stimulation. 274 
Freezing, defined as a lack of movement except for respiration was recorded every 10 sec by a 275 
trained observer for a total of 18 sampling intervals. The mean number of observations 276 
indicating freezing was expressed as a percentage of the total number of observations. The 277 
exploration of the fear conditioning box during the training and activity burst produced by electric 278 
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foot-shock were automatically detected by an infrared beam system and analyzed using TSE 279 
software.   280 
 281 
Morris water maze 282 
The water maze paradigm (Morris et al., 1982) was performed in a circular tank (diameter 180 283 
cm; height 75 cm).  It was located in a room with various distal cues.  The tank was filled with 284 
water (40 cm depth) maintained at 23°C, which was made opaque by the addition of a nontoxic 285 
white paint.  Inside the pool was a removable, circular (12 cm in diameter) Plexiglas platform 0.5 286 
cm below the surface of the water.  On the first two days, each mouse received visible platform 287 
training that consisted of four consecutive trials of climbing onto the visible platform (with a black 288 
plastic brick placed above it) until each subject was able to climb without help. For the hidden 289 
platform task, the mice were given four consecutive trials per day starting from four different 290 
pseudo-randomized start locations, with a 15 min inter-trial interval.  Mice were allowed to 291 
search for the hidden platform for 60 s.  If the mice did not find the platform within 60 s, they 292 
were guided to it. Mice were allowed to rest on the platform for 15 s after each trial.  The hidden 293 
platform task was composed of two phases: (1) 10 days (acquisition phase-days 3-13) with a 294 
hidden platform in located in the center of the target quadrant; (2) reversal phase (day 14) with 295 
the hidden platform located in the center of the quadrant opposite to the original target quadrant.  296 
Reversal platform training was conducted without changing any distal visual cues.  Probe trials 297 
in which the escape platform was removed from the pool were conducted on days 10 (target 298 
quadrant), 13 (target quadrant), and 15 (opposite quadrant).  During the memory test (probe 299 
trials), the platform was removed from the tank, and the mice were allowed to swim in the maze 300 
for 60 s. The swimming path of the mice was recorded by a video camera and analyzed with the 301 
computer-based tracking software Videomot 2 (TSE Systems, RRID:SCR_014334).  The 302 
percentage of swim distance spent in the platform quadrant and the latency to find the platform 303 
were analyzed.  304 
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 305 
Rotarod test 306 
Motor coordination and skill learning were assessed using an accelerating Rotarod (Stoelting).  307 
Starting speed for the Rotarod began at 4 rpm and increased to 40 rpm over a 5-min period.  308 
Mice were tested 4 times daily for 2 consecutive days with an inter-trial interval of 1 h between 309 
tests.  The latency to fall off the rod was measured for each trial. 310 
 311 
Elevated plus maze test 312 
The elevated plus-maze test for anxiety-related behaviors was performed as previously 313 
described (Todorovic et al., 2007).  Briefly, mice were placed in the center platform of the 314 
elevated plus maze and allowed to explore for 5 min.  Animal behavior was recorded by a video 315 
camera connected to a PC and analyzed by videotracking software (VideoMot 2, TSE Systems, 316 
RRID:SCR_014334).  The percentage of time spent in the open and closed arms were 317 
recorded.  Shift of preference from the open to the closed arms was interpreted as an increase 318 
of anxiety-like behavior.  Locomotor activity was determined with this test by the distance 319 
traveled. 320 
 321 
Open field test 322 
General exploratory activity and anxiety were assessed in an open field test. Mice were placed 323 
in the center of an open field apparatus (50 x 50 cm) protected with 10 cm high opaque walls 324 
and allowed to explore for 5 min.  The field was divided into 16 equal squares (12.5 cm x 12.5 325 
cm), consisting of 12 outer squares and 4 inner squares.  Animal behavior was recorded by a 326 
video camera connected to a PC and analyzed by videotracking software (VideoMot 2, TSE 327 
Systems, RRID:SCR_014334).  The amount of time spent in the inner and outer squares and 328 
the total distance traveled was measured.  329 
 330 
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 331 
Acoustic startle and prepulse inhibition 332 
Acoustic startle and prepulse inhibition test were performed as previously described (Pitts et al., 333 
2012).  Mice were placed in the startle chamber (Responder-X, Columbus Instruments) and 334 
allowed a 5 min acclimation period with the background noise (70 dB) continuously present.  335 
Following the acclimation period, two blocks of trials were administered to assess the acoustic 336 
startle response and prepulse inhibition, respectively.  The first block of trials consisted of 8 sets 337 
of 4 types of trials that were randomly distributed.  Startle stimuli (40 ms) of varying intensities 338 
were administered, with an interstimulus interval of 15 s.  The stimulus intensities were 80, 90, 339 
100, and 110 dB. Baseline activity was assessed by a set of no-stimulus trials.  The startle 340 
amplitude was defined as the peak response during a 100 ms sampling window beginning with 341 
the onset of the startle stimulus.  Mean startle amplitudes were derived by subtracting the 342 
average startle amplitudes of stimulus intensities employed (80–110 dB) from the no-stimulus 343 
trial (70 dB).  The second block of trials consisted of 8 sets of 5 trial types, distributed randomly 344 
and separated by 20 s interstimulus intervals.  The trial types were (1) no-stimulus/background 345 
noise (70 dB); (2) 40 ms, 110 dB startle alone; (3–5) 110 dB startle preceded 100 ms by one of 346 
three 20 ms prepulses at the following intensities: 74, 80, 86 dB.  The startle amplitude for each 347 
subject at each of the different prepulse intensities was calculated using the following formula: 348 
prepulse inhibition (PPI)=100−100×[response amplitude for prepulse stimulus paired with startle 349 
stimulus/response amplitude for startle stimulus alone].  350 
 351 
Electrophysiology 352 
Extracellular recordings were performed as described previously (Lawrence et al., 2014).  353 
Hippocampi of wild-type or mutant mice (8-12 weeks) were rapidly removed and briefly chilled in 354 
ice-cold artificial CSF (aCSF) (consisting of the following: 130 mM NaCl, 3.5 mM KCl, 10 mM 355 
glucose, 1.25 mM NaH2PO4, 2.0 mM CaCl2, 1.5 mM MgSO4 and 24 mM NaHCO3 (equilibrated 356 
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with 95% O2/5% CO2, pH 7.4).  Transverse slices 350 μm thick were prepared with a Vibratome 357 
(Leica; VT1200S) and maintained at least 1 h in a holding chamber containing aCSF.  The 358 
slices were then transferred to a recording chamber and perfused (3 mL/min) with aCSF at 359 
32°C.  CA1 field EPSPs (fEPSPs) were recorded with a glass electrode filled with 3 M NaCl 360 
(resistance 1-1.5 MΩ) by stimulating the Schaffer collateral fibers through a bipolar stimulating 361 
electrode.  The slope of the initial rising phase (20–60% of the peak amplitude) of the fEPSP 362 
was used as a measure of the postsynaptic response.  Basal synaptic neurotransmission was 363 
studied by plotting stimulus strength or fiber volley against fEPSP slope to generate input–364 
output relationships. Paired-pulse facilitation (PPF) was defined as the second fEPSP slope 365 
divided by the first at various inter-stimulus intervals (10, 50, 90, 130, 170, 210 and 250 ms).  366 
For the LTP and long-term depression (LTD) measurements a minimum of 20 min of baseline 367 
stimulation (0.05 Hz) was recorded every minute at an intensity that evoked a response 40% of 368 
the maximum response.  The strong tetanic LTP induction protocol consisted of two 100-Hz 369 
tetani (1 s each), with an interval of 20 s between tetani.  The weak LTP induction protocol 370 
consisted of 900 pulses given at 10-Hz. To induce NMDA receptor-dependent LTD, a 1-Hz and 371 
0.5-Hz single pulse stimuli were delivered for 15 and 30 min, respectively (900 stimuli). To 372 
induce mGluR-dependent LTD, slices were incubated with 100 μM (S) −3,5- 373 
dihydroxyphenylglycine (DHPG) (Torcis, Cat# 0805) for 5 min. For the depotentiation study LTP 374 
was evoked by HFS with two trains of 100 Hz (20 s between tetani). Ten minutes after LTP 375 
induction, depotentiation was induced by low frequency stimulation consisting of 900 pulses 376 
delivered at 1 Hz for 15 min. fEPSP responses were recorded using a computer with WinLTP 377 
data acquisition software (WinLTP Ltd, Bristol, UK). For pharmacological studies, JNK-in-8 378 
(Selleckchem, Cat# S 4901) (6μM in aCSF with 10% DMSO) or vehicle were applied for 20 min 379 
prior to testing and were maintained throughout the recording period. 380 
For excitatory post-synaptic current (EPSC) measurements, mice (6 – 10 weeks old) 381 
were anesthetized with isoflurane (Sigma Aldrich, Cat# 792632) and perfused with ice cold 382 
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sucrose solution containing: 200 mM sucrose, 20 mM glucose, 5 mM KCl, 1.2 mM NaH2PO4, 25 383 
mM NaHCO3, 0.5 mM CaCl2, 7 mM MgCl2, 1.3 mM ascorbic acid and 2.4 mM sodium pyruvate.  384 
Transverse sections (350 μm) of the hippocampus were made and then incubated in aCSF at 385 
34°C (20 min) before storing at room temperature.  The aCSF for these experiments was 386 
composed of: 125 mM NaCl, 10 mM glucose, 2.8 mM KCl, 1 mM NaH2PO4, 26 mM NaHCO3, 2 387 
mM CaCl2, 1.5 mM MgSO4.  Whole-cell voltage clamp recordings were done at 32°C utilizing an 388 
EPC-10 amplifier and Patchmaster acquisition software (HEKA Instruments Inc., Bellmore, NY, 389 
RRID: SCR_000034).  Data acquisition and analysis was performed on a MacPro computer 390 
(Apple Inc., Cupertino, CA).  Bicuculline (30 μM) (Tocris, Cat# 0130) and CGP-55845 (1 μM) 391 
(Tocris, Cat# 1248) were added to the artificial aCSF to block GABAA and GABAB responses, 392 
respectfully.  Both sucrose and artificial CSF solutions were continually bubbled with 393 
95%O2/5%CO2.  Patch pipettes were filled with an intracellular solution containing: 130 mM Cs-394 
gluconate, 5 mM NaCl, 0.5 mM CaCl2, 2 mM MgCl2, 10 mM HEPES, 5 mM Cs4BAPTA, 2 mM 395 
MgATP, 0.3 mM Na2GTP. The intracellular solution was titrated to pH 7.2 and 280 mOsm.  CA1 396 
principal cells were held at either -70 or +50 mV to measure the AMPA and NMDA receptor 397 
components of EPSCs, respectively. Stimulation of the Schaffer collaterals synapsing onto the 398 
CA1 cells was performed using an A360 stimulus isolation unit (World Precision Instruments, 399 
Sarasota, FL) with a monopolar platinum iridium electrode placed in the stratum radiatum 400 
approximately 350 μm from the cell body.  The stimulation intensity was adjusted to be 401 
approximately 75% of the threshold for firing an action potential. Peak amplitudes were 402 
analyzed utilizing Igor Pro v.6.3 (RRID: SCR000325). 403 
 404 
Experimental design and statistical analysis  405 
Data were statistically analyzed using StatView (SAS Institute, Cary, NC) and GraphPad 406 
Prism 6 software (GraphPad, San Diego, CA). Student’s t-test was used for comparing two 407 
conditions, and ANOVA was used with Bonferroni post hoc test for comparing more than two 408 
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conditions. All data are expressed as means ± SEM.  The accepted level of significance was 409 
p ≤ 0.05, indicated by an asterisk; p values ≤0.01 are indicated by double asterisks, while p 410 
values ≤ 0.001 are indicated by triple asterisks. 411 
412 
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Results 413 
The aim of this study was to examine the impact of JIP1-regulated JNK activation on neuronal 414 
function and behavior. To accomplish this aim we generated a novel mouse model harboring a 415 
T103A point mutation in the Jip1 gene (also known as Mapk8ip1).  These mutant 416 
Mapk8ip1T103A/T103A mice (JIP1TA) exhibit a profound defect in JIP1-mediated JNK activation 417 
compared to control JIP1WT animals.  We therefore used this mutant mouse to determine the 418 
contribution of JIP1-mediated JNK activation to NMDA-dependent receptor signaling, memory 419 
and synaptic plasticity. 420 
JIP1 expression in hippocampal neurons 421 
Our initial studies were designed to examine the expression of JIP1 protein in the hippocampus.  422 
Immunohistochemical staining of tissue sections demonstrated that JIP1 is expressed in the 423 
CA1, CA3, and the dentate gyrus (DG) regions of the hippocampus (Fig. 1A).  JIP1 was 424 
primarily found on dendrites (colocalization with MAP2) and to a lesser extent on cell bodies 425 
(colocalization with NeuN) of the CA1/CA3 pyramidal and DG granule neurons (Fig. 1A). 426 
We next examined the hippocampal architecture of JIP1TA and JIP1WT mice.  Qualitative 427 
analysis of Nissl- (Fig. 1 B,C) and Golgi-stained (Fig. 2A) coronal sections did not reveal 428 
differences in hippocampus morphology between JIP1TA and JIP1WT mice.  Moreover, analysis 429 
of basal and apical dendrites from Golgi-stained CA1 pyramidal neurons revealed no significant 430 
differences in dendritic branching, spine density, or spine type (Fig. 2A-E).  In addition, the 431 
intensity and distribution of the neuronal marker NeuN (t(6) = 0.89, p=0.41; two-tailed unpaired 432 
Student’s t-test), the dendritic marker MAP2 (t(6) = 0.71, p=0.51; two-tailed unpaired Student’s t-433 
test), the GABAergic interneuron marker GAD67 (t(6)= 0.27, p=0.79; two-tailed unpaired 434 
Student’s t-test), and the glial marker GFAP (t(6) = 0.44, p=0.67; two-tailed unpaired Student’s t-435 
test), were similar in JIP1TA and JIP1WT mice (Fig. 1B-D).  Collectively, these data indicate that 436 
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the Thr103Ala mutation in JIP1 did not cause detectable changes in basic hippocampus 437 
morphology.   438 
JIP1-mediated JNK activation in the hippocampus 439 
We have previously demonstrated that JIP1TA mice exhibit defects in metabolic stress-induced 440 
JNK activation in adipose tissue (Morel et al., 2010).  To test whether the Thr103Ala mutation in 441 
JIP1 also caused defects in JNK activation in neural tissue, we examined a model of JIP1-442 
dependent JNK activation (kainate excitotoxicity) in the hippocampus.  Examination of the DG 443 
following short-term exposure to kainate caused JIP1-dependent JNK activation and 444 
phosphorylation of the JNK substrate cJun and JIP1-independent increased expression of cJun 445 
and cFos (Whitmarsh et al., 2001).  We found that kainate caused a similar increase in cJun 446 
and cFos expression in JIP1TA and JIP1WT mice (Fig. 3B,C).  In contrast, kainate caused 447 
increased cJun phosphorylation in JIP1WT, but not JIP1TA mice (Fig. 3A).  These data 448 
demonstrate that the Thr103Ala mutation suppresses JIP1-mediated JNK activation in the 449 
hippocampus.  Time-course analysis confirmed that cJun phosphorylation in the hippocampus 450 
of kainate-stimulated JIP1WT mice was strongly suppressed in JIP1TA mice after exposure to 451 
kainate  (two-way ANOVA: genotype F(1,32)= 15.11, p<0.001; time F(3,32)= 34.26, p<0.001; 452 
genotype x time F(3,32) = 5.05, p=0.005) (Fig. 3D,E).  These data extend our previous finding that 453 
JIP1TA mice exhibit defects in JIP1-dependent JNK activation in adipose tissue (Morel et al., 454 
2010) to demonstrate that JIP1TA mice also exhibit profound defects in JIP1-mediated JNK 455 
activation in the hippocampus.   456 
To test how JIP1-mediated JNK activation contributes to a physiologically relevant 457 
response, we examined the effect of contextual fear conditioning, which was previously shown 458 
to cause transient JNK activation in the dorsal hippocampus (Sherrin et al., 2010).  Immunoblot 459 
analysis using antibodies to JNK and phospho-JNK was performed to assess changes in JNK 460 
activation in dorsal hippocampal extracts from JIP1WT and JIP1TA mice that were subjected to 461 
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single-trial contextual fear conditioning.  Extracts were prepared at various times following the 462 
single-trial to correspond to the consolidation phase of contextual fear (Igaz et al., 2002). JNK 463 
immunoblot analysis detects the 46 kDa (JNK1?1 & JNK1?1) and 54 kDa isoforms (JNK2?2, 464 
JNK2?2, and JNK3?2) in brain (Davis, 2000).  We found that contextual fear conditioning 465 
caused an increase in 46-kDa phospho-JNK in JIP1WT mice at 30 min (176 ± 12% of naïve 466 
control mice; Bonferroni post hoc test, p<0.001) and 60 min (127 ± 8% of naïve; Bonferroni post 467 
hoc test, p= 0.09) (Fig. 4). In contrast, we found that JIP1TA mice exhibited decreased 46-kDa 468 
phospho-JNK at 30 min (75 ± 11% of naïve; Bonferroni post hoc test, p=0.011), 60 min (53 ± 469 
7% of naïve; p<0.001) and 180 min (79 ± 6% of naïve; p=0.009) after contextual fear 470 
conditioning (two-way ANOVA: genotype F(1,50)= 15.11, p<0.001; time F(4,50)= 10.42, p<0.001; 471 
genotype x time F(4,50) = 22.11, p<0.001) (Fig. 4).  These data demonstrate that the JIP1 472 
Thr103Ala mutation suppresses JNK activation caused by contextual fear conditioning.   473 
 474 
JIP1-mediated JNK activation suppresses NMDA-dependent synaptic plasticity 475 
JNK activation is associated with mechanistic changes in synaptic plasticity in the hippocampus 476 
(Wang et al., 2004; Chen et al., 2005; Zhu et al., 2005; Li et al., 2007; Yang et al., 2011).  477 
Consequently, synaptic plasticity may be altered by JIP1-dependent JNK activation in the 478 
context of fear conditioning (Fig. 4).  We therefore examined synaptic transmission in JIP1WT 479 
and JIP1TA mice.   480 
Basal synaptic transmission at Schaffer collateral-CA1 synapses in JIP1WT and JIP1TA 481 
mice was characterized through the input-output (I/O) relationship of field excitatory 482 
postsynaptic potentials (fEPSPs).  Analysis revealed that the fEPSP slopes, plotted against the 483 
stimulation strength, were comparable in slices from JIP1WT and JIP1TA mice (two-way repeated 484 
measures ANOVA: genotype F(1,420) = 0.23, p= 0.63; amplitude F(14,442)= 79.27, p<0.001; 485 
genotype x amplitude F(14,420)= 0.35, p=0.63) (Fig. 5A).  Similarly, when the fEPSPs slopes were 486 
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plotted as a function of increasing fiber volley amplitudes, no differences between JIP1WT and 487 
JIP1TA mice were detected (Fig. 5B).  Moreover, paired-pulse facilitation, indicative of 488 
presynaptic plasticity (Zucker and Regehr, 2002), at Schaffer collateral-CA1 synapses from 489 
JIP1TA mice was similar to JIP1WT mice at several inter-pulse intervals  (two-way repeated 490 
measures ANOVA: genotype F(1,223) = 0.08, p= 0.78); interval F(6,223)= 13.56, p<0.001; genotype 491 
x interval F(8,208)= 0.15, p=0.98) (Fig. 5C).  These data demonstrate similar basal synaptic 492 
transmission in the hippocampi of JIP1TA and JIP1WT mice.   493 
To determine whether the JIP1 Thr103Ala mutation affects NMDA receptor-dependent 494 
forms of synaptic plasticity (Citri and Malenka, 2008), LTP was measured using a high-495 
frequency tetanic stimulation protocol (HFS: 2 trains of 1 sec 100-Hz, separated by 20 sec).  496 
Similar potentiation was produced in both JIP1WT and JIP1TA mice (Fig. 5D; fEPSPs were 497 
potentiated to 145 ± 7% for JIP1WT and 146 ± 4% for JIP1TA) (t(18) = 0.12, p=0.89; two-tailed 498 
unpaired Student’s t-test), indicating that the ability to induce LTP with strong stimulation was 499 
unimpaired in JIP1TA mice. We next examined whether the threshold stimulation for induction of 500 
LTP (Hu et al., 2007) differed between JIP1WT and JIP1TA mice.  A 900-pulse train of 10 Hz 501 
stimulation resulted in a modest, but detectable, degree of LTP in slices obtained from JIP1TA 502 
mice (Fig. 5E; 122 ± 4% of baseline at 50-60 min after LTP induction), though with minimal 503 
post-tetanic potentiation, whereas fEPSPs in JIP1WT slices were not potentiated (Fig. 5E; 92.1 ± 504 
5.5 % of baseline) (t(18) = 7.61, p<0.001; two-tailed unpaired Student’s t-test), with a trend toward 505 
depression.  These data demonstrate that LTP could be induced at lower frequencies in JIP1TA 506 
mice compared with JIP1WT mice.   507 
We also examined the induction of NMDA receptor-dependent LTD (Collingridge et al., 508 
2010) in JIP1WT and JIP1TA mice.  We found that low-frequency stimulation (LFS), consisting of 509 
900 single pulses at 1 Hz for 15 min, generated robust LTD in JIP1WT mice, but LTD was absent 510 
in JIP1TA mice (Fig. 5F) (JIP1WT mice, 72 ± 2%; JIP1TA mice, 98 ± 3%; p<0.01) (t (18) = 7.05, 511 
p<0.001; two-tailed unpaired Student’s t-test). In view of the similar post-tetanic depression 512 
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[initial dip] between JIP1WT and JIP1TA brain slices, we determined whether JIP1TA mice exhibit 513 
other forms of LTD.  We therefore induced LTD by delivering the same number of single pulses 514 
(900) at 0.5 Hz for 30 min (Fig. 5G).   This form of LTD also relies on NMDA receptors (Dudek 515 
and Bear, 1992), but depends to a greater degree on release of calcium from intracellular stores 516 
(Nakano et al., 2004). This LTD protocol produced equivalent depression in both JIP1TA and 517 
JIP1WT mice (Fig. 5G; JIP1WT, 68% ± 3%; JIP1TA, 66% ± 2%) (t(26) = 0.55, p=0.58; two-tailed 518 
unpaired Student’s t-test).  These data indicate that disruption of JIP1-mediated JNK activation 519 
reduces the optimal frequency stimulation for LTD, while enabling LTP at lower stimulation 520 
frequencies at Schaffer collateral-CA1 synapses (Fig. 5H). 521 
Two different forms of LTD coexist at Schaffer collateral-CA1 synapses in the 522 
hippocampus, one dependent on NMDA receptors and another dependent on the activity of 523 
metabotropic glutamate receptors (mGluRs), specifically mGluR5 (Huber et al., 2001). Thus, we 524 
next examined a possible effect of the JIP1TA mutation on mGluR-dependent LTD. We found 525 
that a 5-min bath application of 100 μM DHPG (a group I mGluR agonist) to acute slices 526 
resulted in a persistent depression of Schaffer collateral-evoked responses that was 527 
comparable between JIP1TA and JIP1WT slices (Fig. 5I; 62% ± 1% of baseline at 60 min post-528 
drug application for JIP1TA versus 65% ± 8% for JIP1WT) (t(18) = 0.68, p=0.49; two-tailed unpaired 529 
Student’s t-test). These results suggest that whereas the JIP1TA mutation blocks the NMDAR-530 
dependent forms of LTD, it does not affect the mGluR-dependent form.  531 
Another important aspect of synaptic modification is synaptic depotentiation, namely that 532 
the synaptic potentiation could be subsequently reversed by LFS. In view of the finding that two 533 
trains of HFS at 100 Hz induced significant LTP in response to a 20-s inter-tetanus interval in 534 
both groups of mice (Fig. 5J), we used this HFS protocol followed by LFS 10 min later (900 535 
pulses at 1 Hz) to induce depotentiation. One hour after the LFS, the evoked responses in both 536 
JIP1WT and JIP1TA mice dropped to the baseline level (100% ± 4% compared with baseline 537 
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before the HFS for JIP1WT, and 101% ± 3% for JIP1TA) (t(18) = 0.23, p=0.82; two-tailed unpaired 538 
Student’s t-test), indicating effective LFS-induced depotentiation in both genotypes.  539 
We next tested whether application of a selective inhibitor of JNK would mimic effects of 540 
the JIP1 Thr103Ala mutation on NMDA-receptor dependent forms of LTP and LTD. Slices were 541 
obtained from wild-type mice and exposed either to the selective JNK inhibitor JNK-in-8 (6 μM) 542 
or solvent (aCSF) for 20 min prior to stimulation protocols. The drug application was maintained 543 
throughout the recording period. Basal synaptic transmission was not affected by JNK-in-8 as 544 
indicated by the unchanged input–output relation (two-way repeated measures ANOVA: 545 
genotype F(1,308) = 0.88, p= 0.35); amplitude F(14,308)= 61.73, p<0.001; genotype x amplitude 546 
F(14,308)= 0.35, p=0.63) and unchanged paired-pulse facilitation (two-way repeated measures 547 
ANOVA: genotype F(1,132) = 0.46, p= 0.56); interval F(6,132)= 42.12, p<0.001; genotype x interval 548 
F(6,132)= 1.17, p=0.11)  (Fig. 6A, B). In addition, inhibiting JNK activation in slices did not affect 549 
HFS LTP (Fig. 6C, 60 min after 2X100Hz tetanization: 127 ± 6% of baseline for vehicle-treated 550 
slices vs. 125 ± 5% for JNK-in-8-treated slices) (t(22) = 0.25, p=0.81; two-tailed unpaired 551 
Student’s t-test).  However, JNK inhibition prevented the induction of LTD using the 1 Hz 552 
stimulation protocol (Fig. 6D - vehicle-treated slices, 77 ± 3%; JNK-in-8-treated slices, 101 ± 553 
4%; p<0.05) (t(18) = 4.81, p<0.001; two-tailed unpaired Student’s t-test). The latter result closely 554 
parallels the result obtained for the JIP1TA slices (cf. Fig. 5F).  Thus, these data confirm that 555 
JIP1-mediated JNK activation plays an essential, but differential, role in certain forms NMDA-556 
receptor dependent synaptic plasticity. 557 
 558 
JIP1TA mice exhibit increased NMDA receptor signaling 559 
It is established that JIP scaffold proteins influence NMDA receptor activity (Kennedy et al., 560 
2007).  The induction of synaptic plasticity at lower stimulation frequencies detected in JIP1TA 561 
mice compared with JIP1WT mice (Fig. 6) may therefore be mediated by changes in NMDA 562 
receptor signaling. Indeed, we found increased expression of NMDA receptor subunits GluN1 563 
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(t(8) = 2.66, p=0.029; two-tailed unpaired Student’s t-test), GluN2A (t(8) = 2.85, p=0.037; two-564 
tailed unpaired Student’s t-test),  and GluN2B proteins (t(8) = 2.65, p=0.027; two-tailed unpaired 565 
Student’s t-test)  (but not mRNA) in the whole hippocampus of JIP1TA mice compared to JIP1WT 566 
mice (Fig. 7A-C).  Control studies detected no differences in the expression of the AMPA 567 
receptor subunits GluA1 and GluA2 (Fig. 7A).  The increased expression of NMDA receptor 568 
subunits was also detected in hippocampal synaptoneurosomes (Fig. 7D) and by increased cell 569 
surface detection of GluN1 by immunofluorescence analysis of hippocampal neurons (t(16) = 570 
2.85, p=0.012; two-tailed unpaired Student’s t-test), (Fig. 7E,F) cultured from JIP1TA mice 571 
compared with JIP1WT mice.  These changes were associated with biochemical evidence of 572 
increased NMDA receptor activity through assessment of downstream signaling changes, 573 
including increased GluN2B Tyr1472 phosphorylation (Salter and Kalia, 2004) (Fig. 7A), 574 
increased cFos mRNA expression (t(9) = 3.31, p=0.009; two-tailed unpaired Student’s t-test),  575 
(Bading et al., 1993) (Fig. 7G), ERK phosphorylation (t(8) = 3.11, p=0.017; two-tailed unpaired 576 
Student’s t-test) (Xia et al., 1996) (Fig. 7H), and CREB phosphorylation (t(8) = 5.25, p=0.008; 577 
two-tailed unpaired Student’s t-test) (Ginty et al., 1993) (Fig. 7H).  Control experiments 578 
demonstrated that the expression of KIF17, a microtubule motor that transports GluN2B 579 
vesicles and regulates synaptic plasticity (Yin et al., 2011; Yin et al., 2012), was similar in 580 
JIP1WT and JIP1TA mice (Fig. 7H).  Together, these data indicate that JIP1TA mice may exhibit 581 
increased NMDA receptor signaling in the hippocampus compared with JIP1WT mice.   582 
To functionally test whether NMDA receptor signaling was increased in JIP1TA mice 583 
compared with JIP1WT mice, we examined excitatory post-synaptic currents (EPSCs) via whole-584 
cell recordings of CA1 pyramidal cells in acute hippocampus slices.  For CA1 pyramidal cells 585 
held under voltage clamp at -70 mV, the response to Schaffer collateral stimulation is primarily 586 
mediated by AMPA receptors. The NMDA receptor-mediated component of EPSCs is readily 587 
distinguished from the AMPA receptor component by measuring current responses at a 588 
membrane potential of +50 mV approximately 30 ms after stimulation when approximately 90% 589 
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of the AMPA receptor response has decayed (Liao et al., 1995; Myme et al., 2003).  We found 590 
that the average NMDA receptor-mediated peak EPSC was 1.6-fold larger in JIP1TA mice 591 
compared with JIP1WT mice (t(31) = 2.41, p=0.022; two-tailed unpaired Student’s t-test) (Fig. 592 
8A,B), while the average peak amplitude of the AMPA receptor-mediated EPSCs were similar in 593 
JIP1TA and JIP1WT mice (t(31) = 0.28, p=0.77; two-tailed unpaired Student’s t-test) (Fig. 8A,C).  594 
These findings were reflected in the NMDA/AMPA peak current ratio calculated for each cell 595 
tested.  JIP1WT mice had a NMDA/AMPA receptor ratio of 37 ± 4%, whereas JIP1TA mice yielded 596 
a significantly larger ratio of 50 ± 4%  (t(31) = 2.21, p=0.038; two-tailed unpaired Student’s t-test) 597 
(Fig. 8D).  This analysis demonstrated that NMDA receptor signaling is increased in JIP1TA 598 
hippocampal neurons compared with those of JIP1WT mice.  To confirm this conclusion, we 599 
examined NMDA receptor-stimulated gene expression in primary JIP1TA and JIP1WT 600 
hippocampal neurons.  We found that NMDA-induced expression of brain-derived neurotrophic 601 
factor (Bdnf) mRNA (Ghosh et al., 1994; Tabuchi et al., 2000) and cFos mRNA (Bading et al., 602 
1993; Xia et al., 1996) by JIP1TA neurons were increased when compared with JIP1WT neurons  603 
([two-way ANOVA: genotype F(1,29)= 70.26, p<0.001; time F(2,29)= 39.7, p<0.001; genotype x time 604 
F(2,29)= 14.91, p<0.001; for Bdnf mRNA]; [two-way ANOVA: genotype F(1,30)= 17.67, p<0.001; 605 
time F(2,30)= 182.1, p<0.001; genotype x time F(2,30)= 7,98, p<0.001; for cFos mRNA]) (Fig. 606 
8E,F). Together, these data indicate that the increased NMDA-mediated signaling detected in 607 
the JIP1TA hippocampus is due to enhanced NMDA receptor activity in individual neurons. ?608 
 609 
JIP1-mediated JNK activation in locomotor, sensory and emotional responses 610 
To address the possibility that increased NMDA receptor signaling in JIP1TA mice compared 611 
with JIP1WT mice may cause behavioral changes, we first performed a battery of basic 612 
behavioral tests of CNS function on JIP1WT and JIP1TA mice.  We found that anxiety-related 613 
behavior was increased in JIP1TA mice.  For example, JIP1TA mice in an elevated plus maze 614 
spent less time in the open arms, compared with JIP1WT mice (t(18) = 2.79, p= 0.012; two-tailed 615 
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unpaired Student’s t-test), with no changes in locomotor activity (t(18) = 0.76, p= 0.45; two-tailed 616 
unpaired Student’s t-test) (Fig. 9, A-C).  Moreover, JIP1TA mice spent significantly less time in 617 
the center (t(18) = 5.40, p< 0.001; two-tailed unpaired Student’s t-test) and more in the periphery 618 
(t(18) = 6.46, p< 0.001; two-tailed unpaired Student’s t-test) during an open field test compared to 619 
JIP1WT animals  (Fig. 9, D-E). Consistent with previous reports (Grillon et al., 1998), elevated 620 
anxiety in JIP1TA mice was accompanied by an enhancement of the startle response to strong 621 
acoustic stimuli (two-way repeated measures ANOVA: genotype F(1,42)= 5.42, p= 0.035; stimulus 622 
F(3,42) = 105.42, p< 0.001; genotype x stimulus= 9.25, p< 0.001) (Fig. 9F).  No changes in 623 
sensorimotor gating (pre-pulse inhibition) were observed (two-way repeated measures ANOVA: 624 
genotype F(1, 28)= 0.13, p= 0.722) (Fig. 9G).  We also found that “fast” improvement in motor 625 
coordination on the accelerating Rotarod was comparable between JIP1WT and JIP1TA mice.  626 
However, during the second day of Rotarod training JIP1TA mice did not display improved “slow” 627 
skill learning, unlike JIP1WT mice, as indicated by significant genotype x trial interaction value 628 
(two-way repeated measures ANOVA: genotype F(1,98)=4.84, p=0.045), trial F(7,98)= 7.73, 629 
p<0.001; genotype x trial F(7,98)=3.34, p= 0.003) (Fig. 9H). Taken together, these data 630 
demonstrate that JIP1TA mice have normal sensory and motor activity, and attention function.  631 
However, JIP1TA mice displayed increased levels of anxiety-related behaviors and altered skill 632 
learning.   633 
Improved extinction-resistant contextual fear memory in JIP1TA mice 634 
Contextual fear conditioning triggers JIP1-dependent JNK activation in the hippocampus (Fig. 635 
4).  Moreover, JNK activation in the hippocampus is implicated in some forms of hippocampus-636 
dependent memory (Sherrin et al., 2011).  We therefore compared JIP1WT and JIP1TA mice to 637 
determine if JIP1-mediated JNK activation is required for the behavioral response to contextual 638 
fear conditioning.  The mice received either  “weak” (0.4 mA shock) or “strong” (0.8 mA shock) 639 
training and were then re-exposed to the chamber 24 h later to assess long-term fear memory 640 
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(Shalin et al., 2006). The two training procedures were employed to adjust for nociceptive 641 
sensitivity and also to test whether a “weak” stimulation protocol, similar to one that facilitated 642 
synaptic plasticity (cf. Fig. 5E), results in enhanced hippocampal memory in JIP1TA mice. JIP1TA 643 
and JIP1WT mice showed no differences in freezing or activity during the exploration period 644 
before the foot-shock (data not shown), or after the 0.8mA foot-shock delivery (t(19) = 0.46, 645 
p=0.65; two-tailed unpaired Student’s t-test). (Fig. 10A, right panel). Significantly enhanced 646 
contextual freezing of JIP1TA mice compared with JIP1WT controls was found 24 h after “strong” 647 
training (Fig. 10A, left panel, mean percentage freezing: JIP1TA = 85 ± 3%; JIP1WT= 59 ± 4%) 648 
(t(19) = 5.11, p<0.001; two-tailed unpaired Student’s t-test). This enhancement of contextual fear 649 
was more pronounced in JIP1TA mice when the “weak” paradigm was used (Fig. 10B, mean 650 
percentage freezing:  JIP1TA = 81 ± 4%; JIP1WT = 44 ± 5%) (t(26) = 5.26, p<0.001; two-tailed 651 
unpaired Student’s t-test).  We next investigated short-term memory by testing JIP1TA and 652 
JIP1WT mice immediately or 1 hr after the “strong” conditioning paradigm.  We found that JIP1TA 653 
and JIP1WT mice displayed similar responses in the both contextual tests (t(20) = 0.18, p=0.85; 0 654 
hr post-conditioning, two-tailed unpaired Student’s t-test) (t(26) = 0.11, p= 0.75; 1hr post-655 
conditioning, two-tailed unpaired Student’s t-test) (Fig. 10A, left panel).  Thus, JIP1TA and JIP1WT 656 
mice did not differ in exploration activity, nociceptive reaction to electric shock, post-shock 657 
freezing response, or short-term fear memory. These findings also indicate that the increased 658 
anxiety phenotype observed with the JIP1TA mice does not appear to fundamentally affect 659 
shock-induced and post-shock behaviors, including contextual fear conditioning and learning 660 
(see also Fig. 11).  Nevertheless, JIP1TA mice exhibited increased long-term fear memory 661 
compared with JIP1WT mice (Fig. 10A,B).   662 
 We then tested whether contextual fear memory is differentially affected in JIP1TA and 663 
JIP1WT mice following antagonism of the NMDA receptors. JIP1TA and JIP1WT mice were 664 
implanted with cannulae into the dorsal hippocampus and subjected to contextual fear 665 
conditioning. A selective NMDA receptor antagonist, D,L-2-amino-5-phosphonovaleric acid 666 
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(APV; 10 μg/ml; 0.5 ml) or solvent (aCSF), was infused into the dorsal hippocampus (i.h.) 15 667 
min prior to training. Both JIP1TA and JIP1WT mice given APV showed substantially reduced 668 
freezing to context compared to mice that received aCSF prior to conditioning (two-way 669 
ANOVA: genotype F(1,36)= 8.76, p= 0.0054; treatment F(1,36)= 143.06, p< 0.001; genotype x 670 
treatment= 5.29, p=0.027 ) (Fig. 10C). However, no differences between APV-treated JIP1TA 671 
mice and APV-treated JIP1WT mice were observed (Bonferroni post hoc test: p= 0.62) (Fig. 672 
10C), indicating that memory facilitating effects observed in JIP1TA were mediated via activation 673 
of NMDA receptors.  Taken together, these experiments show that blockade of JIP1-mediated 674 
JNK activation can improve contextual learning induced by a relatively mild learning protocol 675 
and that enhanced NMDA receptor function is required for this facilitatory effect of JIP1TA 676 
mutation on learning. 677 
Previous studies have demonstrated that activation of hippocampal NMDA receptor 678 
regulates fear extinction (Szapiro et al., 2003; Suzuki et al., 2004; Leaderbrand et al., 2014), 679 
and that NMDA receptor blockade can prevent fear extinction in a variety of fear-related tasks 680 
(Santini et al., 2001; Sotres-Bayon et al., 2007). Thus, we extended our cognitive evaluation of 681 
JIP1TA mice by assessing contextual fear extinction to further assess the link of JIP1-JNK 682 
activation through NMDA receptors.  Conditioned JIP1TA and JIP1WT mice were subjected to 683 
brief (3-min) daily extinction trials (E1-E7) by non-reinforced placement in the training context for 684 
7 days after contextual conditioning. During the extinction trials, JIP1TA mice exhibited almost 685 
unchanged freezing responses, indicating nearly fully impaired extinction compared to JIP1WT 686 
mice (repeated measure ANOVA: genotype F(1,108)= 388.76, p= p< 0.001; time F(6,108)= 36.26, p< 687 
0.001; F(6,108) genotype x time= 25.35, p< 0.001) (Fig. 10D). Overall, these results indicate that 688 
the enhanced contextual fear observed in JIP1TA mice is strongly resistant to extinction. 689 
Finally, cue-dependent fear conditioning was assessed in JIP1TA mice and JIP1WT 690 
controls. As with contextual fear conditioning, mice received either a “strong” or a “weak” 691 
training protocol, both consisting of a single pairing of tone and shock at 0.8mA and 0.4mA, 692 
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respectively. In both protocols, JIP1TA mice, compared to JIP1WT controls, displayed significantly 693 
more freezing when re-exposed to the tone 24 h post-training (Fig. 10E, left panel, mean 694 
percentage freezing: “weak” cued test- JIP1TA = 66 ± 3%; JIP1WT= 44 ± 4%) (t(20) = 3.71, p=0.01; 695 
two-tailed unpaired Student’s t-test) (Fig. 10E, right panel, mean percentage freezing: “strong” 696 
cued test- JIP1TA = 70 ± 3%; JIP1WT= 55 ± 4%) (t(20) = 2.65, p=0.015; two-tailed unpaired 697 
Student’s t-test), indicating that JIP1TA mice display memory enhancement in the fear learning 698 
tasks in a manner involving both amygdala- and hippocampus-dependent memory systems. 699 
 700 
Improved spatial learning in JIP1TA mice 701 
We next tested JIP1TA and JIP1WT mice using the Morris water maze (MWM) protocol, a 702 
hippocampus-dependent spatial memory task (Morris et al., 1982).  During the hippocampus-703 
independent visible portion of the training, both JIP1TA and JIP1WT mice readily learned to find 704 
the marked platform (Fig. 11A).  Mice were then trained to swim to a hidden platform located in 705 
a fixed location of the pool (target quadrant, T, Fig. 11A,D).  JIP1TA mice had significantly 706 
decreased escape latencies compared to JIP1WT mice on days 6-9 and day 12 of training (two-707 
way repeated measures ANOVA: genotype F(1,208) = 11.03, p= 0.0049); time F(8,208)= 21.01, 708 
p<0.001; genotype x time F(8,208)= 0.74, p=0.65) (Fig. 11A). However, JIP1TA and JIP1WT mice 709 
did not differ in the time spent in the platform-containing quadrant during probe trials on day 10  710 
(Fig. 11B, 36 ± 3% of time in quadrant T for JIP1TA; 35 ± 2% JIP1WT) (t(26) = 0.27, p=0.783; two-711 
tailed unpaired Student’s t-test) and day 13 (Fig. 11C, 38 ± 5% of time in quadrant T for JIP1TA 712 
mice; 36 ± 3% JIP1WT mice) (t(26) = 0.34, p=0.734; two-tailed unpaired Student’s t-test).  713 
Although JIP1TA mice did not display preference for the target quadrant during probe trials, the 714 
decrease in escape latency during training suggests that the presence of the JIP1 Thr103Ala 715 
mutation appears to moderately affect gradual learning of the hidden platform water maze task. 716 
 To test whether JIP1TA mice display enhanced fast spatial learning, we performed a 717 
reversal of the hidden platform in the MWM.  The hidden platform was moved to the opposite 718 
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quadrant of the pool (new target quadrant (NT)) and the mice were trained to swim to this new 719 
location for four trials separated by 15-20 min (Fig. 11D). JIP1TA mice learned significantly faster 720 
to swim to the new platform location compared to control mice (two-way repeated measures 721 
ANOVA: genotype F(1,78) = 16.37, p= 0.0012; time F(3,78)= 1.98, p=0.13; genotype x time F(3,78)= 722 
1.86, p=0.15) (Fig. 11E). Moreover, the JIP1TA mice displayed increased preference for the NT 723 
quadrant during a probe trial given on probe day 15 (Fig. 11F; time spent in NT quadrant: 41 ± 724 
2% for JIP1TA; 23 ± 4% for JIP1WT) (t(26) = 4.02, p<0.001; two-tailed unpaired Student’s t-test).  725 
This enhancement in spatial reversal learning of the new platform location was accompanied by 726 
a decrease in the percent of time JIP1TA mice spent searching for the platform in the previously 727 
correct quadrant (O) (t(26)= 2.34, p=0.028; two-tailed unpaired Student’s t-test) (Fig. 11F).  728 
These data indicate that the Thr103Ala mutation in JIP1 allows for improved fast spatial learning. 729 
JNK binding is required for JIP1-mediated NMDA receptor regulation of learning and 730 
memory 731 
To confirm that JIP1-mediated JNK activation plays a critical role in NMDA receptor-dependent, 732 
hippocampus-dependent learning and memory, we tested an independent mouse model of 733 
defective JIP1-mediated JNK activation: JIP1 lacking the JNK binding domain (JBD).  To create 734 
a mouse model lacking the JBD of JIP1 (JIP1∆JBD mice), the core of the JBD (Leu160-Asn161-735 
Leu162) mediating a hydrophobic interaction of JIP1 with JNK (Whitmarsh et al., 2001; Heo et al., 736 
2004) was replaced with Gly160-Arg161-Gly162 in JIP∆JBD ?mice (Fig. 12A-B).  Immunoblot analysis 737 
of brain extracts from JIP1WT and JIP1∆JBD mice indicated similar levels of JIP1 protein 738 
expression (Fig. 12C).  To establish that the ∆JBD mutation blocks JIP1-mediated JNK 739 
activation in vivo, we compared kainate-induced excitotoxicity in the hippocampus of JIP1WT and 740 
JIP1∆JBD mice.  This analysis demonstrated that kainate caused similar increases in cJun 741 
expression in the dentate gyrus of JIP1WT and JIP1∆JBD mice, but kainate-stimulated cJun 742 
phosphorylation was markedly suppressed in JIP1∆JBD mice compared with JIP1WT mice (Fig. 743 
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12D,E).  These data confirm that JIP1∆JBD mice represent a model of defective JIP1-mediated 744 
JNK signaling.   745 
We then examined contextual and cued fear conditioning to assess the effect of the 746 
JIP1∆JBD mutation on learning and memory.  The JIP1∆JBD mice displayed a significantly 747 
increased conditioned freezing response in both learning tasks compared to the JIP1WT mice 748 
when tested at 24 hours after training (Fig. 13A left panel: mean percentage contextual 749 
freezing; JIP1WT = 58 ± 3%; JIP1∆JBD = 89 ± 3%; t(18)= 6.30, p<0.001; two-tailed unpaired 750 
Student’s t-test; Fig. 13A right panel: mean percentage cued freezing; JIP1WT = 51 ± 1%; 751 
JIP1∆JBD = 69 ± 6%; t(20)= 2.97, p=0.007; two-tailed unpaired Student’s t-test), a result very 752 
similar to that observed for the JIP1TA mice (Fig. 10).  JIP1∆JBD mice exhibited enhanced 753 
learning in the MWM (two-way repeated measures ANOVA: genotype F(1,162) = 26.04, p<0.001); 754 
time F(8,162)= 126.7, p<0.001; genotype x time (8,162)= 1.75, p= 0.84) , and spent significantly more 755 
time in the target quadrant compared to control JIP1WT mice when subjected to probe trials on 756 
day 9 (t(18) = 4.02, p<0.001) (Fig. 13C, left panel; 41 ± 2% of time in quadrant T for JIP1∆JBD; 32 757 
± 1% of time in quadrant T for JIP1WT) and day 13 (Fig. 13C, right panel; 48 ± 4% of time in 758 
quadrant T for JIP1∆JBD; 36 ± 3% of time in quadrant T for JIP1WT) (t(18) = 2.44, p=0.027; two-759 
tailed unpaired Student’s t-test).  This was an unexpected finding, as JIP1TA mice did not show 760 
enhanced memory retention in the hidden platform MWM task (cf. Fig. 11B, C). The larger 761 
phenotype in the JIP1∆JBD mice in the MWM compared to the JIP1TA mice may result from a 762 
greater effect of the JNK binding site mutation on JIP1-mediated JNK activation than the 763 
mutation of the T103 phosphorylation site on JIP1. 764 
 We then examined reversal learning by moving the hidden platform to the opposite 765 
quadrant (Fig. 13D, left panel).  Similar to JIP1TA mice, the JIP1∆JBD mice showed shorter 766 
latencies than control mice in finding the new platform location during a one-day trial period 767 
(data not shown).  Moreover, JIP1∆JBD mice spent significantly more time in the new target 768 
quadrant compared to JIP1WT control mice (Fig. 13D, right panel; mean percentage of time 769 
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spent in new target quadrant [NT] was 49 ± 3%, for JIP1∆JBD; 28 ± 4% for JIP1WT) (t(18) = 4.21, 770 
p<0.001; two-tailed unpaired Student’s t-test).  Furthermore, like JIP1TA mice, we found 771 
significantly increased expression of GluN1, GluN2A, and GluN2B in the hippocampus of 772 
JIP1∆JBD mice as compared to hippocampi from JIP1WT mice (Fig. 13E) and increased ERK 773 
activation (t(8) = 2.57, p=0.033; two-tailed unpaired Student’s t-test) (Fig. 13F).   774 
Together, these analyses of JIP1TA and JIP1∆JBD mice confirm that loss of JIP1-mediated 775 
JNK activation enhances NMDA-dependent hippocampus-dependent memory.   776 
777 
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Discussion 778 
The JIP1 scaffold protein can assemble a functional JNK signaling module formed by members 779 
of the mixed-lineage protein kinase family of MAP3K, the MAP2K family member MKK7, and 780 
JNK (Whitmarsh et al., 1998).  However, JIP1 also functions as an adapter protein that 781 
mediates transport by microtubule motor proteins (Fu and Holzbaur, 2014), including kinesin-1 782 
(Verhey et al., 2001; Whitmarsh et al., 2001) and dynein (Standen et al., 2009; Fu and 783 
Holzbaur, 2013).  These two functions of JIP1 compromise the interpretation of loss-of-function 784 
studies focused on the analysis of JIP1 knockout mice (Whitmarsh et al., 2001; Kennedy et al., 785 
2007).  To overcome this limitation, we studied two mouse models with germ-line mutations in 786 
the Jip1 gene that prevent JIP1-mediated JNK activation. First, a point mutation of the JIP1 787 
phosphorylation site Thr103 (by replacement with Ala) in JIP1TA mice suppresses JIP1-mediated 788 
JNK activation (Fig. 3) by disrupting the regulated interaction of mixed-lineage protein kinases 789 
with JIP1 (Morel et al., 2010).  Second, a three-residue mutation of the JIP1 site that binds JNK 790 
in JIP1∆JBD mice prevents JIP1-mediated JNK activation (Fig. 12).  These complementary 791 
mouse models therefore provided an opportunity to selectively disrupt JIP1-mediated JNK 792 
activation in vivo.  793 
 It is established that the JIP1 scaffold protein mediates JNK activation in the neuronal 794 
response to excitotoxin (Whitmarsh et al., 2001) and in adipose tissue during metabolic stress 795 
responses (Jaeschke et al., 2004; Morel et al., 2010).  The results of the present study extend 796 
these findings to neural functioning by demonstrating that JIP1-linked JNK activation in the 797 
hippocampus regulates contextual fear conditioning in a NMDA receptor-dependent fashion.  798 
This finding builds on the previous demonstration that JNK1-deficient mice exhibit enhanced 799 
contextual fear conditioning (Sherrin et al., 2010) and altered synaptic plasticity (Li et al., 2007). 800 
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We further show that JIP1-mediated JNK activation regulates NMDA receptor signal 801 
transduction associated with an altered threshold for LTP, decreased long-term fear memory, 802 
and decreased spatial memory (Figs. 5, 6, 8, 10, 11 & 13).  These observations are consistent 803 
with the conclusion that JNK normally functions to negatively regulate mechanisms responsible 804 
for learning and memory (Sherrin et al., 2011).  We found that the enhanced learning in JIP1 805 
mutant mice was associated with an increase in the NMDA receptor component of the synaptic 806 
response, and enhanced activity of downstream pathways that facilitate induction of NMDA 807 
receptor-dependent LTP.  This is consistent with previous reports that have separately 808 
implicated both JNK signaling (Sherrin et al., 2010) and CA1 hippocampal NMDA receptors in 809 
contextual fear conditioning, spatial learning, and synaptic plasticity (Kutsuwada et al., 1996; 810 
Tsien et al., 1996; Tang et al., 1999; Liu et al., 2004; Lau and Zukin, 2007; Yashiro and Philpot, 811 
2008; Brigman et al., 2010).  These data indicate that JIP1-mediated JNK activation may 812 
constrain synaptic plasticity, learning and memory through attenuation of NMDA receptor 813 
function. Furthermore, decreases in JIP1 level and/or localization affecting JNK activity, perhaps 814 
resulting from distinct signaling pathways (e.g. glutamate-mediated down-regulation of JIP1 815 
level in growth cones (Dajas-Bailador et al., 2014); Ca2+-dependent degradation of JIP1 816 
(Allaman-Pillet et al., 2003), would thus be predicted to reduce this constraint, leading to 817 
enhanced learning and memory.  818 
The increased NMDA receptor signaling caused by loss of JIP1-mediated JNK activation 819 
in JIP1TA mice is associated with increased expression of the NMDA receptor subunits GluN2A 820 
and GluN2B (Fig. 7).  This increase in the levels of NMDA receptor subunits is significant 821 
because it is established that changes in GluN2A and GluN2B expression cause altered 822 
plasticity and memory (Tang et al., 1999; Brigman et al., 2010; Chao et al., 2013).  This may be 823 
mediated by extending the integration time window for NMDA receptor signaling coincident with 824 
pre- and postsynaptic activity, and decreasing the threshold for inducing long-term synaptic 825 
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changes. Indeed, a constraint by JIP1-JNK on plasticity thresholds may, in turn, regulate 826 
information processing and learning (Kiyama et al., 1998; Hawasli et al., 2007; Hu et al., 2007).  827 
This is consistent with the observation that loss of JIP1-mediated JNK activation in JIP1TA mice 828 
enables the establishment of LTP at lower stimulation frequencies (Fig. 5H), with the converse 829 
being a requirement for higher stimulation frequencies needed in the presence of JIP1-JNK 830 
activation.  The mechanism of JIP1-dependent regulation of NMDA receptor subunit expression 831 
(Fig. 7A,B) remains to be determined and may include changes in NMDA receptor membrane 832 
insertion, internalization, or lateral movement into synapses (Fig 14).  Additionally, JIP1 may 833 
regulate NMDA receptor subunit expression through a post-transcriptional mechanism (Fig. 14). 834 
Indeed, it is known that GluN1, GluN2 and GluN2B protein expression can be regulated by 835 
CPEB3 (Chao et al., 2013), that GluN2A protein expression can be regulated by CPEB1 836 
(Udagawa et al., 2012; Swanger et al., 2013), and that GluN2B expression can be regulated by 837 
a microRNA (Harraz et al., 2012).  Strikingly, the learning and memory phenotypes of Cpeb3-/- 838 
mice associated with increased NMDA receptor expression (Chao et al., 2013) are similar to the 839 
phenotypes of the mice with defects in JIP1 function studied in the present study (JIP1TA and 840 
JIP1∆JBD mice).   841 
 It is possible that increased expression of NMDA receptor subunits only partially 842 
accounts for the learning and memory phenotypes of JIPTA and JIP1∆JBD mice. Indeed, it has 843 
been shown that cFyn mediates phosphorylation of the NMDA receptor subunit GluN2B on 844 
Y1472, resulting in increased NMDA receptor activity (Salter and Kalia, 2004) by attenuating 845 
NMDA receptor internalization (Roche et al., 2001; Prybylowski et al., 2005), increasing the 846 
proper localization of the GluN2B NMDA receptors at synapses (Nakazawa et al., 2006), and 847 
enhancing GluN2B NMDA receptor-mediated currents at CA1 synapses (Yang et al., 2012).  In 848 
the present study, increased GluN2B Y1472 phosphorylation resulted from disruption of JIP1-849 
mediated JNK activation in JIP1TA mice (Fig. 7A), also perhaps contributing to the observed 850 
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increase in NMDA receptor signaling. This change in GluN2B Y1472 phosphorylation may be 851 
caused by JIP1-mediated recruitment of cFyn (Kennedy et al., 2007) or by JNK-mediated 852 
recruitment of PSD-95/Fyn complex (Kim et al., 2007).  Another potential contributing factor may 853 
be the binding of JIP1 to LRP8, a protein that regulates NMDAR signaling (Stockinger et al., 854 
2000; Beffert et al., 2005).  Finally, it is possible that JIP1-mediated interactions with the 855 
exchange factors Ras-GRF1 and Tiam1 may contribute to increased NMDA receptor dependent 856 
activation of the ERK pathway and activity-dependent actin remodeling critical for synaptic 857 
plasticity and memory (Buchsbaum et al., 2002; Krapivinsky et al., 2003; Tolias et al., 2007).  858 
Contextual-fear learning recruits both the hippocampus and amygdala, while cued-fear 859 
learning relies on the amygdala (Phillips and LeDoux, 1992).  JIPTA and JIP1∆JBD mice displayed 860 
enhancement in both contextual and cued fear conditioning (Figs. 10, 13). As such, these 861 
learning enhancements suggest that JIP1-mediated JNK activation is also important in the 862 
amygdala. Although JIP1 is expressed in amygdala (preliminary observations), JNK signaling 863 
and the importance of JIP1 in the amygdala have yet to be thoroughly investigated. We 864 
hypothesize that the observed contextual-learning enhancement is, at least, in part due to a lack 865 
of hippocampal JIP1-mediated JNK signaling. Not only is signal transduction altered in this 866 
region, but JIPTA and JIP1∆JBD mice also demonstrate an improved spatial water maze memory, 867 
which classically relies on the hippocampus.  868 
Genetic anomalies on the JNK pathway have also been associated with a subset of 869 
other psychiatric disorders (Coffey, 2014). However, the degree to which and the mechanism 870 
by which JNK is involved is unknown. JIP1TA mutant mice display a range of behaviors 871 
including exaggerated fear responses to cues associated with the danger, difficulty suppressing 872 
fear behavior even when these cues no longer predict danger, elevated acoustic startle 873 
response, and anxiety-like behaviors that may represent rodent homologues of the symptoms 874 
that are diagnostic for trauma- and stressor-related disorders, such as posttraumatic stress 875 
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disorder (PTSD) (Shalev et al., 2017). These responses may be regulated by JIP1-mediated 876 
JNK signaling in the hippocampus, the amygdala, or in various cortical regions that interconnect 877 
to form the neural circuits that promote adaptation to stress and fear conditioning. Interestingly, 878 
we have shown that intrahippocampal infusion with a JNK inhibitor prevents stress-induced 879 
changes in fear conditioning (Sherrin et al, 2010). Thus, it is possible that drugs that target 880 
the function of JIP1 to positively regulate JNK activity or NMDA receptor function (Myers and 881 
Davis, 2007; Feder et al., 2014; Ori et al., 2015; Mataix-Cols et al., 2017) may therefore be 882 
useful for the treatment of PTSD or anxiety disorders marked by abnormal fear learning and 883 
maladaptive processing of information related to threat. Our study provides a proof-of-concept 884 
that validates this approach using a model organism. An exciting future possibility is the 885 
application of this strategy to the treatment of human fear and anxiety.  886 
Overall, the results of this study suggest that JNK activation caused by the JIP1 scaffold 887 
protein constrains learning and memory in a NMDA receptor-dependent fashion.  This role of 888 
JIP1 starkly differs from the related protein JIP2 that acts to promote NMDA receptor signaling 889 
by a JNK-independent mechanism (Kennedy et al., 2007).  Our studies of JIP1 therefore 890 
establish a role for the JIP1-JNK pathway in NMDA receptor-dependent regulation of memory 891 
acquisition, consolidation, and retention.  892 
893 
  
?
39 
??? ?
References 894 
 895 
Allaman-Pillet N, Storling J, Oberson A, Roduit R, Negri S, Sauser C, Nicod P, Beckmann JS, 896 
Schorderet DF, Mandrup-Poulsen T, Bonny C (2003) Calcium- and proteasome-897 
dependent degradation of the JNK scaffold protein islet-brain 1. J Biol Chem 278:48720-898 
48726. 899 
 900 
Bading H, Ginty DD, Greenberg ME (1993) Regulation of gene expression in hippocampal 901 
neurons by distinct calcium signaling pathways. Science 260:181-186. 902 
 903 
Baptista J, Mercer C, Prigmore E, Gribble SM, Carter NP, Maloney V, Thomas NS, Jacobs PA, 904 
Crolla JA (2008) Breakpoint mapping and array CGH in translocations: comparison of a 905 
phenotypically normal and an abnormal cohort. Am J Human Genet 82:927-936. 906 
 907 
Beffert U, Weeber EJ, Durudas A, Qiu SF, Masiulis I, Sweatt JD, Li WP, Adelmann G, Frotscher 908 
M, Hammer RE, Herz J (2005) Modulation of synaptic plasticity and memory by Reelin 909 
involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47:567-579. 910 
 911 
Brigman JL, Wright T, Talani G, Prasad-Mulcare S, Jinde S, Seabold GK, Mathur P, Davis MI, 912 
Bock R, Gustin RM, Colbran RJ, Alvarez VA, Nakazawa K, Delpire E, Lovinger DM, 913 
Holmes A (2010) Loss of GluN2B-containing NMDA receptors in CA1 hippocampus and 914 
cortex impairs long-term depression, reduces dendritic spine density, and disrupts 915 
learning. J Neurosci 30:4590-4600. 916 
 917 
Buchsbaum RJ, Connolly BA, Feig LA (2002) Interaction of Rac exchange factors Tiam1 and 918 
Ras-GRF1 with a scaffold for the p38 mitogen-activated protein kinase cascade. Mol 919 
Cell Biol 22:4073-4085. 920 
 921 
Chao HW, Tsai LY, Lu YL, Lin PY, Huang WH, Chou HJ, Lu WH, Lin HC, Lee PT, Huang YS 922 
(2013) Deletion of CPEB3 Enhances Hippocampus-Dependent Memory via Increasing 923 
Expressions of PSD95 and NMDA Receptors. J Neurosci 33:17008-17022. 924 
 925 
Chen JT, Lu DH, Chia CP, Ruan DY, Sabapathy K, Xiao ZC (2005) Impaired long-term 926 
potentiation in c-Jun N-terminal kinase 2-deficient mice. J Neurochem 93:463-473. 927 
 928 
Citri A, Malenka RC (2008) Synaptic plasticity: Multiple forms, functions, and mechanisms. 929 
Neuropsychopharmacol 33:18-41. 930 
 931 
Coffey ET (2014) Nuclear and cytosolic JNK signalling in neurons. Nat Rev Neurosci 15:285-932 
299. 933 
 934 
Collingridge GL, Peineau S, Howland JG, Wang YT (2010) Long-term depression in the CNS. 935 
Nat Rev Neurosci 11:459-473. 936 
 937 
Curran BP, Murray HJ, O'Connor JJ (2003) A role for c-Jun N-terminal kinase in the inhibition of 938 
long-term potentiation by interleukin-1beta and long-term depression in the rat dentate 939 
gyrus in vitro. Neuroscience118:347-357. 940 
 941 
Dajas-Bailador F, Bantounas I, Jones EV, Whitmarsh AJ (2014) Regulation of axon growth by 942 
the JIP1-AKT axis. J Cell Sci 127:230-239. 943 
  
?
40 
??? ?
 944 
Davis RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell 103:239-252. 945 
 946 
de Anda FC, Rosario AL, Durak O, Tran T, Graff J, Meletis K, Rei D, Soda T, Madabhushi R, 947 
Ginty DD, Kolodkin AL, Tsai LH (2012) Autism spectrum disorder susceptibility gene 948 
TAOK2 affects basal dendrite formation in the neocortex. Nat Neurosci 15:1022-1031. 949 
 950 
Dickens M, Rogers JS, Cavanagh J, Raitano A, Xia Z, Halpern JR, Greenberg ME, Sawyers CL, 951 
Davis RJ (1997) A cytoplasmic inhibitor of the JNK signal transduction pathway. Science 952 
277:693-696. 953 
 954 
Dudek SM, Bear MF (1992) Homosynaptic long-term depression in area CA1 of hippocampus 955 
and effects of N-methyl-D-aspartate receptor blockade. Proc Natl Acad Sci U S A 956 
89:4363-4367. 957 
 958 
Feder A, Parides MK, Murrough JW, Perez AM, Morgan JE, Saxena S, Kirkwood K, Aan Het 959 
Rot M, Lapidus KA, Wan LB, Iosifescu D, Charney DS (2014) Efficacy of intravenous 960 
ketamine for treatment of chronic posttraumatic stress disorder: a randomized clinical 961 
trial. JAMA Psychiatry 71:681-688. 962 
 963 
Fu MM, Holzbaur EL (2013) JIP1 regulates the directionality of APP axonal transport by 964 
coordinating kinesin and dynein motors. J Cell Biol 202:495-508. 965 
 966 
Fu MM, Holzbaur EL (2014) Integrated regulation of motor-driven organelle transport by 967 
scaffolding proteins. Trends Cell Biol 24:564-574. 968 
 969 
Ghosh A, Carnahan J, Greenberg ME (1994) Requirement for BDNF in activity-dependent 970 
survival of cortical neurons. Science 263:1618-1623. 971 
 972 
Ginty DD, Kornhauser JM, Thompson MA, Bading H, Mayo KE, Takahashi JS, Greenberg ME 973 
(1993) Regulation of CREB phosphorylation in the suprachiasmatic nucleus by light and 974 
a circadian clock. Science 260:238-241. 975 
 976 
Giza J, Urbanski MJ, Prestori F, Bandyopadhyay B, Yam A, Friedrich V, Kelley K, D'Angelo E, 977 
Goldfarb M (2010) Behavioral and cerebellar transmission deficits in mice lacking the 978 
autism-linked gene islet brain-2. J Neurosci 30:14805-14816. 979 
 980 
Grillon C, Morgan CA, Davis M, Southwick SM (1998) Effects of experimental context and 981 
explicit threat cues on acoustic startle in Vietnam veterans with posttraumatic stress 982 
disorder. Biol Psychiat 44:1027-1036. 983 
 984 
Harraz MM, Eacker SM, Wang XQ, Dawson TM, Dawson VL (2012) MicroRNA-223 is 985 
neuroprotective by targeting glutamate receptors. Proc Natl Acad Sci U S A 109:18962-986 
18967. 987 
 988 
Hawasli AH, Benavides DR, Nguyen C, Kansy JW, Hayashi K, Chambon P, Greengard P, 989 
Powell CM, Cooper DC, Bibb JA (2007) Cyclin-dependent kinase 5 governs learning and 990 
synaptic plasticity via control of NMDAR degradation. Nat Neurosci 10:880-886. 991 
 992 
Heo YS, Kim SK, Seo CI, Kim YK, Sung BJ, Lee HS, Lee JI, Park SY, Kim JH, Hwang KY, Hyun 993 
YL, Jeon YH, Ro S, Cho JM, Lee TG, Yang CH (2004) Structural basis for the selective 994 
  
?
41 
??? ?
inhibition of JNK1 by the scaffolding protein JIP1 and SP600125. EMBO J 23:2185-995 
2195. 996 
 997 
Hu HL, Real E, Takamiya K, Kang MG, Ledoux J, Huganir RL, Malinow R (2007) Emotion 998 
enhances learning via norepinephrine regulation of AMPA-Receptor trafficking. Cell 999 
131:160-173. 1000 
 1001 
Huber KM, Roder JC, Bear MF (2001) Chemical induction of mGluR5- and protein synthesis--1002 
dependent long-term depression in hippocampal area CA1. J Neurophysiol 86:321-325. 1003 
 1004 
Igaz LM, Vianna MR, Medina JH, Izquierdo I (2002) Two time periods of hippocampal mRNA 1005 
synthesis are required for memory consolidation of fear-motivated learning. J Neurosci 1006 
22:6781-6789. 1007 
 1008 
Inoue A, Sawatari E, Hisamoto N, Kitazono T, Teramoto T, Fujiwara M, Matsumoto K, Ishihara 1009 
T (2013) Forgetting in C. elegans is accelerated by neuronal communication via the TIR-1010 
1/JNK-1 pathway. Cell Rep 3:808-819. 1011 
 1012 
Jaeschke A, Czech MP, Davis RJ (2004) An essential role of the JIP1 scaffold protein for JNK 1013 
activation in adipose tissue. Genes Dev 18:1976-1980. 1014 
 1015 
Kant S, Standen CL, Morel C, Jung DY, Kim JK, Swat W, Flavell RA, Davis RJ (2017) A Protein 1016 
Scaffold Coordinates SRC-Mediated JNK Activation in Response to Metabolic Stress. 1017 
Cell Rep 20:2775-2783. 1018 
 1019 
Kennedy NJ, Martin G, Ehrhardt AG, Cavanagh-Kyros J, Kuan CY, Rakic P, Flavell RA, 1020 
Treistman SN, Davis RJ (2007) Requirement of JIP scaffold proteins for NMDA-1021 
mediated signal transduction. Genes Dev 21:2336-2346. 1022 
 1023 
Kim MJ, Futai K, Jo J, Hayashi Y, Cho K, Sheng M (2007) Synaptic accumulation of PSD-95 1024 
and synaptic function regulated by phosphorylation of serine-295 of PSD-95. Neuron 1025 
56:488-502. 1026 
 1027 
Kiyama Y, Manabe T, Sakimura K, Kawakami F, Mori H, Mishina M (1998) Increased thresholds 1028 
for long-term potentiation and contextual learning in mice lacking the NMDA-type 1029 
glutamate receptor epsilon1 subunit. J Neurosci 18:6704-6712. 1030 
 1031 
Korobova F, Svitkina T (2010) Molecular architecture of synaptic actin cytoskeleton in 1032 
hippocampal neurons reveals a mechanism of dendritic spine morphogenesis. Mol Biol 1033 
Cell 21:165-176. 1034 
 1035 
Krapivinsky G, Krapivinsky L, Manasian Y, Ivanov A, Tyzio R, Pellegrino C, Ben-Ari Y, Clapham 1036 
DE, Medina I (2003) The NMDA receptor is coupled to the ERK pathway by a direct 1037 
interaction between NR2B and RasGRF1. Neuron 40:775-784. 1038 
 1039 
Kunde SA, Rademacher N, Tzschach A, Wiedersberg E, Ullmann R, Kalscheuer VM, Shoichet 1040 
SA (2013) Characterisation of de novo MAPK10/JNK3 truncation mutations associated 1041 
with cognitive disorders in two unrelated patients. Human Genet 132:461-471. 1042 
 1043 
Kutsuwada T, Sakimura K, Manabe T, Takayama C, Katakura N, Kushiya E, Natsume R, 1044 
Watanabe M, Inoue Y, Yagi T, Aizawa S, Arakawa M, Takahashi T, Nakamura Y, Mori 1045 
  
?
42 
??? ?
H, Mishina M (1996) Impairment of suckling response, trigeminal neuronal pattern 1046 
formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice. 1047 
Neuron 16:333-344. 1048 
 1049 
Lau CG, Zukin RS (2007) NMDA receptor trafficking in synaptic plasticity and neuropsychiatric 1050 
disorders. Nat Rev Neurosci 8:413-426. 1051 
 1052 
Lawrence JL, Tong M, Alfulaij N, Sherrin T, Contarino M, White MM, Bellinger FP, Todorovic C, 1053 
Nichols RA (2014) Regulation of Presynaptic Ca2+, Synaptic Plasticity and Contextual 1054 
Fear Conditioning by a N-terminal beta-Amyloid Fragment. J Neurosci 34:14210-14218. 1055 
 1056 
Leaderbrand K, Corcoran KA, Radulovic J (2014) Co-activation of NR2A and NR2B subunits 1057 
induces resistance to fear extinction. Neurobiol Learn Mem 113:35-40. 1058 
 1059 
Li XM, Li CC, Yu SS, Chen JT, Sabapathy K, Ruan DY (2007) JNK1 contributes to metabotropic 1060 
glutamate receptor-dependent long-term depression and short-term synaptic plasticity in 1061 
the mice area hippocampal CA1. Eur J Neurosci 25:391-396. 1062 
 1063 
Liao D, Hessler NA, Malinow R (1995) Activation of postsynaptically silent synapses during 1064 
pairing-induced LTP in CA1 region of hippocampal slice. Nature 375:400-404. 1065 
 1066 
Liu L, Wong TP, Pozza MF, Lingenhoehl K, Wang Y, Sheng M, Auberson YP, Wang YT (2004) 1067 
Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic 1068 
plasticity. Science 304:1021-1024. 1069 
 1070 
Mataix-Cols D et al. (2017) D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior 1071 
Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A 1072 
Systematic Review and Meta-analysis of Individual Participant Data. JAMA Psychiatry 1073 
74:501-510. 1074 
 1075 
Morel C, Standen CL, Jung DY, Gray S, Ong H, Flavell RA, Kim JK, Davis RJ (2010) 1076 
Requirement of JIP1-Mediated c-Jun N-Terminal Kinase Activation for Obesity-Induced 1077 
Insulin Resistance. Mol Cell Biol 30:4616-4625. 1078 
 1079 
Morris RG, Garrud P, Rawlins JN, O'Keefe J (1982) Place navigation impaired in rats with 1080 
hippocampal lesions. Nature 297:681-683. 1081 
 1082 
Morrison DK, Davis RJ (2003) Regulation of MAP kinase signaling modules by scaffold proteins 1083 
in mammals. Annu Rev Cell Dev Biol 19:91-118. 1084 
 1085 
Mukherjee PK, DeCoster MA, Campbell FZ, Davis RJ, Bazan NG (1999) Glutamate receptor 1086 
signaling interplay modulates stress-sensitive mitogen-activated protein kinases and 1087 
neuronal cell death. J Biol Chem 274:6493-6498. 1088 
  1089 
Myers KM, Davis M (2007) Mechanisms of fear extinction. Mol Psychiatry 12:120-150. 1090 
 1091 
Myme CIO, Sugino K, Turrigiano GG, Nelson SB (2003) The NMDA-to-AMPA ratio at synapses 1092 
onto layer 2/3 pyramidal neurons is conserved across prefrontal and visual cortices. J 1093 
Neurophysiol 90:771-779. 1094 
 1095 
  
?
43 
??? ?
Nakano M, Yamada S, Udagawa R, Kato N (2004) Frequency-dependent requirement for 1096 
calcium store-operated mechanisms in induction of homosynaptic long-term depression 1097 
at hippocampus CA1 synapses. Eur J Neurosci 19:2881-2887. 1098 
 1099 
Nakazawa T, Komai S, Watabe AM, Kiyama Y, Fukaya M, Arima-Yoshida F, Horai R, Sudo K, 1100 
Ebine K, Delawary M, Goto J, Umemori H, Tezuka T, Iwakura Y, Watanabe M, 1101 
Yamamoto T, Manabe T (2006) NR2B tyrosine phosphorylation modulates fear learning 1102 
as well as amygdaloid synaptic plasticity. EMBO J 25:2867-2877. 1103 
 1104 
Nihalani D, Wong HN, Holzman LB (2003) Recruitment of JNK to JIP1 and JNK-dependent JIP1 1105 
phosphorylation regulates JNK module dynamics and activation. J Biol Chem 1106 
278:28694-28702. 1107 
 1108 
Ori R, Amos T, Bergman H, Soares-Weiser K, Ipser JC, Stein DJ (2015) Augmentation of 1109 
cognitive and behavioural therapies (CBT) with d-cycloserine for anxiety and related 1110 
disorders. Cochrane Database Syst Rev:CD007803. 1111 
 1112 
Pellet JB, Haefliger JA, Staple JK, Widmann C, Welker E, Hirling H, Bonny C, Nicod P, Catsicas 1113 
S, Waeber G, Riederer BM (2000) Spatial, temporal and subcellular localization of islet-1114 
brain 1 (IB1), a homologue of JIP-1, in mouse brain. Eur J Neurosci 12:621-632. 1115 
 1116 
Phillips RG, LeDoux JE (1992) Differential contribution of amygdala and hippocampus to cued 1117 
and contextual fear conditioning. Behav Neurosci 106:274-285. 1118 
 1119 
Pitts MW, Raman AV, Hashimoto AC, Todorovic C, Nichols RA, Berry MJ (2012) Deletion of 1120 
selenoprotein P results in impaired function of parvalbumin interneurons and alterations 1121 
in fear learning and sensorimotor gating. Neuroscience 208:58-68. 1122 
 1123 
Prybylowski K, Chang K, Sans N, Kan LL, Vicini S, Wenthold RJ (2005) The synaptic 1124 
localization of NR2B-containing NMDA receptors is controlled by interactions with PDZ 1125 
proteins and AP-2. Neuron 47:845-857. 1126 
 1127 
Roche KW, Standley S, McCallum J, Ly CD, Ehlers MD, Wenthold RJ (2001) Molecular 1128 
determinants of NMDA receptor internalization. Nat Neurosci 4:794-802. 1129 
 1130 
Salter MW, Kalia LV (2004) SRC kinases: A hub for NMDA receptor regulation. Rev Neurosci 1131 
5:317-328. 1132 
 1133 
Santini E, Muller RU, Quirk GJ (2001) Consolidation of extinction learning involves transfer from 1134 
NMDA-independent to NMDA-dependent memory. J Neurosci 21:9009-9017. 1135 
 1136 
Shalev A, Liberzon I, Marmar C (2017) Post-Traumatic Stress Disorder. N Engl J Med 1137 
376:2459-2469. 1138 
 1139 
Shalin SC, Hernandez CM, Dougherty MK, Morrison DK, Sweatt JD (2006) Kinase suppressor 1140 
of Ras1 compartmentalizes hippocampal signal transduction and subserves synaptic 1141 
plasticity and memory formation. Neuron 50:765-779. 1142 
 1143 
Sherrin T, Blank T, Todorovic C (2011) c-Jun N-terminal kinases in memory and synaptic 1144 
plasticity. Rev Neurosci 22:403-410. 1145 
 1146 
  
?
44 
??? ?
Sherrin T, Blank T, Hippel C, Rayner M, Davis RJ, Todorovic C (2010) Hippocampal c-Jun-N-1147 
terminal kinases serve as negative regulators of associative learning. J. Neurosci 1148 
30:13348-13361. 1149 
 1150 
Shoichet SA, Duprez L, Hagens O, Waetzig V, Menzel C, Herdegen T, Schweiger S, Dan B, 1151 
Vamos E, Ropers HH, Kalscheuer VM (2006) Truncation of the CNS-expressed JNK3 in 1152 
a patient with a severe developmental epileptic encephalopathy. Human Genet 118:559-1153 
567. 1154 
 1155 
Sotres-Bayon F, Bush DE, LeDoux JE (2007) Acquisition of fear extinction requires activation of 1156 
NR2B-containing NMDA receptors in the lateral amygdala. Neuropsychopharmacol 1157 
32:1929-1940. 1158 
 1159 
Standen CL, Kennedy NJ, Flavell RA, Davis RJ (2009) Signal transduction cross talk mediated 1160 
by Jun N-terminal kinase-interacting protein and insulin receptor substrate scaffold 1161 
protein complexes. Mol Cell Biol 29:4831-4840. 1162 
 1163 
Stockinger W, Brandes C, Fasching D, Hermann M, Gotthardt M, Herz J, Schneider WJ, Nimpf 1164 
J (2000) The reelin receptor ApoER2 recruits JNK-interacting proteins-1 and -2. J Biol 1165 
Chem 275:25625-25632. 1166 
 1167 
Suzuki A, Josselyn SA, Frankland PW, Masushige S, Silva AJ, Kida S (2004) Memory 1168 
reconsolidation and extinction have distinct temporal and biochemical signatures. J 1169 
Neurosci 24:4787–4795. 1170 
 1171 
Swanger SA, He YA, Richter JD, Bassell GJ (2013) Dendritic GluN2A Synthesis Mediates 1172 
Activity-Induced NMDA Receptor Insertion. J. Neurosci 33:8898-8908. 1173 
 1174 
Szapiro G, Vianna MR, McGaugh JL, Medina JH, Izquierdo I (2003) The role of NMDA 1175 
glutamate receptors, PKA, MAPK, and CAMKII in the hippocampus in extinction of 1176 
conditioned fear. Hippocampus 13:53-58. 1177 
 1178 
Tabuchi A, Nakaoka R, Amano K, Yukimine M, Andoh T, Kuraishi Y, Tsuda M (2000) 1179 
Differential activation of brain-derived neurotrophic factor gene promoters I and III by 1180 
Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor 1181 
Ca2+ channels. J Biol Chem 275:17269-17275. 1182 
 1183 
Tang YP, Shimizu E, Dube GR, Rampon C, Kerchner GA, Zhuo M, Liu G, Tsien JZ (1999) 1184 
Genetic enhancement of learning and memory in mice. Nature 401:63-69. 1185 
 1186 
Todorovic C, Radulovic J, Jahn O, Radulovic M, Sherrin T, Hippel C, Spiess J (2007) 1187 
Differential activation of CRF receptor subtypes removes stress-induced memory deficit 1188 
and anxiety. Eur J Neurosci 25:3385-3397. 1189 
 1190 
Tolias KF, Bikoff JB, Kane CG, Tolias CS, Hu L, Greenberg ME (2007) The Rac1 guanine 1191 
nucleotide exchange factor Tiam1 mediates EphB receptor-dependent dendritic spine 1192 
development. Proc Natl Acad Sci U S A 104:7265-7270. 1193 
 1194 
Tsien JZ, Huerta PT, Tonegawa S (1996) The essential role of hippocampal CA1 NMDA 1195 
receptor-dependent synaptic plasticity in spatial memory. Cell 87:1327-1338. 1196 
 1197 
  
?
45 
??? ?
Udagawa T, Swanger SA, Takeuchi K, Kim JH, Nalavadi V, Shin J, Lorenz LJ, Zukin RS, 1198 
Bassell GJ, Richter JD (2012) Bidirectional Control of mRNA Translation and Synaptic 1199 
Plasticity by the Cytoplasmic Polyadenylation Complex. Mol Cell 47:253-266. 1200 
 1201 
Verhey KJ, Meyer D, Deehan R, Blenis J, Schnapp BJ, Rapoport TA, Margolis B (2001) Cargo 1202 
of kinesin identified as JIP scaffolding proteins and associated signaling molecules. J 1203 
Cell Biol 152:959-970. 1204 
 1205 
Villasana LE, Klann E, Tejada-Simon MV (2006) Rapid isolation of synaptoneurosomes and 1206 
postsynaptic densities from adult mouse hippocampus. J Neurosci Methods 158:30-36. 1207 
 1208 
Wang Q, Walsh DM, Rowan MJ, Selkoe DJ, Anwyl R (2004) Block of long-term potentiation by 1209 
naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated 1210 
via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and 1211 
p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. 1212 
J Neurosci 24:3370-3378. 1213 
 1214 
Weiss LA et al. (2008) Association between microdeletion and microduplication at 16p11.2 and 1215 
autism. New Engl J Med 358:667-675. 1216 
 1217 
Whitmarsh AJ, Cavanagh L, Tournier C, Yasuda L, Davis RJ (1998) Mammalian scaffold 1218 
complex that selectively mediates MAP kinase activation. Science 281:1671-1674. 1219 
 1220 
Whitmarsh AJ, Kuan CY, Kennedy NJ, Kelkar N, Haydar TF, Mordes JP, Appel M, Rossini AA, 1221 
Jones SN, Flavell RA, Rakic P, Davis RJ (2001) Requirement of the JIP1 scaffold 1222 
protein for stress-induced JNK activation. Genes Dev 15:2421-2432. 1223 
 1224 
Winchester CL, Ohzeki H, Vouyiouklis DA, Thompson R, Penninger JM, Yamagami K, Norrie 1225 
JD, Hunter R, Pratt JA, Morris BJ (2012) Converging evidence that sequence variations 1226 
in the novel candidate gene MAP2K7 (MKK7) are functionally associated with 1227 
schizophrenia. Human Mol Genet 21:4910-4921. 1228 
 1229 
Xia Z, Dudek H, Miranti CK, Greenberg ME (1996) Calcium influx via the NMDA receptor 1230 
induces immediate early gene transcription by a MAP kinase/ERK-dependent 1231 
mechanism. J Neurosci 16:5425-5436. 1232 
 1233 
Yang DD, Kuan CY, Whitmarsh AJ, Rincon M, Zheng TS, Davis RJ, Rakic P, Flavell RA (1997) 1234 
Absence of excitotoxicity-induced apoptosis in the hippocampus of mice lacking the Jnk3 1235 
gene. Nature 389:865-870. 1236 
 1237 
Yang HH, Courtney MJ, Martinsson P, Manahan-Vaughan D (2011) Hippocampal long-term 1238 
depression is enhanced, depotentiation is inhibited and long-term potentiation is 1239 
unaffected by the application of a selective c-Jun N-terminal kinase inhibitor to freely 1240 
behaving rats. Eur J Neurosci 33:1647-1655. 1241 
 1242 
Yang K, Trepanier C, Sidhu B, Xie YF, Li HB, Lei G, Salter MW, Orser BA, Nakazawa T, 1243 
Yamamoto T, Jackson MF, MacDonald JF (2012) Metaplasticity gated through 1244 
differential regulation of GluN2A versus GluN2B receptors by Src family kinases. EMBO 1245 
J 31:805-816. 1246 
 1247 
  
?
46 
??? ?
Yashiro K, Philpot BD (2008) Regulation of NMDA receptor subunit expression and its 1248 
implications for LTD, LTP, and metaplasticity. Neuropharmacol 55:1081-1094. 1249 
 1250 
Yin X, Feng X, Takei Y, Hirokawa N (2012) Regulation of NMDA receptor transport: a KIF17-1251 
cargo binding/releasing underlies synaptic plasticity and memory in vivo. J. Neurosci 1252 
32:5486-5499. 1253 
 1254 
Yin XL, Takei Y, Kido MA, Hirokawa N (2011) Molecular Motor KIF17 Is Fundamental for 1255 
Memory and Learning via Differential Support of Synaptic NR2A/2B Levels. Neuron 1256 
70:310-325. 1257 
 1258 
Zhu Y, Pak D, Qin Y, McCormack SG, Kim MJ, Baumgart JP, Velamoor V, Auberson YP, Osten 1259 
P, van Aelst L, Sheng M, Zhu JJ (2005) Rap2-JNK removes synaptic AMPA receptors 1260 
during depotentiation. Neuron 46:905-916. 1261 
 1262 
Zucker RS, Regehr WG (2002) Short-term synaptic plasticity. Annu Rev Physiol 64:355-405. 1263 
?1264 
1265 
  
?
47 
??? ?
Legends?1266 
 1267 
Figure 1.  Analysis of JIP1 expression in the hippocampus.  1268 
(A)  Fluorescent immunohistochemistry of the CA1, CA3, and DG regions of the hippocampus indicates 1269 
that JIP1 (green) predominantly co-localizes with MAP2 (red) in wild-type brain sections (upper panels), 1270 
suggesting relative enrichment of the JIP1 protein in neuronal processes.  Co-localization between JIP1 1271 
(green) and neuron-specific nuclear protein (NeuN) (red) is sparse in the hippocampal subfields (lower 1272 
panels).  Abbreviations: CA1, Cornu Ammonis 1; CA3, Cornu Ammonis 3; DG, dentate gyrus; grDG, 1273 
granular layer of DG; poDG, polymorphic layer of DG; s.l., stratum lucidem; s.l.m., stratum lacunosum 1274 
moleculare; s.p., stratum pyramidale; s.r., stratum radiatum. Scale bar = 50 μm. 1275 
(B) Nissl stain and (NeuN) stain of JIP1WT and JIP1TA coronal hippocampal sections.  Scale bar = 200 μm. 1276 
(C,D)  Pyramidal cells of the CA1 region of JIP1WT and JIP1TA were stained with Nissl, NeuN, the dendritic 1277 
marker MAP2, the astrocytic marker GFAP, and the inhibitory GABAergic marker GAD67 (C).  The 1278 
staining was quantitated (D) (mean ± SEM; n=4; p>0.05; Student’s t–test). Scale bar = 50 μm.  1279 
 1280 
 1281 
 1282 
Figure 2.  Neuronal spine density and dendritic arborization of CA1 pyramidal neurons are similar 1283 
in JIP1WT and JIP1TA mice.  1284 
(A) Representative images of apical and basal dendrites spine morphology in JIP1TA mice and JIP1WT 1285 
littermates. Scale bar = 10 μm. 1286 
(B) Quantitation of basal and apical dendritic spine density (mean ± SEM; n= 5 slices from 5 mice per 1287 
genotype; p>0.05, Student’s t-test).   1288 
(C) Quantitation of different spine types in basal and apical dendrites (mean ± SEM, n= 5 slices from 5 1289 
mice per genotype; p>0.05, Student’s t-test). 1290 
(D,E) Sholl analysis of dendritic arborization of CA1 pyramidal neurons. Values on the x-axis represent 1291 
increasing distance from the soma of the pyramidal cells. Basal and apical dendrites of pyramidal cells 1292 
from n= 5 slices from 5 mice per genotype were examined (mean ± SEM; p>0.05, Student’s t-test).  1293 
 1294 
 1295 
 1296 
Figure 3.  JIP1-dependent JNK activation in the hippocampus is suppressed in JIP1TA mice.   1297 
(A-C)  JIP1WT and JIP1TA mice were treated by systemic injection of kainate.  At 2 h post-treatment, 1298 
sections of the brain were prepared and stained (green) with antibodies to pSer63 cJun (A), cJun (B), or 1299 
cFos (C).  DNA was stained with DAPI (red).  Representative sections of the dentate gyrus of the 1300 
hippocampus are presented.  Scale bar = 75 μm. 1301 
(D,E)  Extracts prepared from the hippocampus of JIP1WT and JIP1TA mice treated with kainate (0 – 60 1302 
mins) were examined by multiplexed ELISA to measure the amount of pSer63-cJun (D) and cJun (E) 1303 
normalized to the amount of JNK.  The data presented are the mean ± SEM (n=5; **, p<0.01, two-way 1304 
ANOVA followed by Bonferroni's post-hoc test).  1305 
 1306 
 1307 
 1308 
Figure 4.  JIP1TA mice exhibit reduced JNK activation in the dorsal hippocampus following 1309 
contextual fear conditioning.   1310 
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Dorsal hippocampal tissue was isolated from naïve mice and from mice at different times after contextual 1311 
fear conditioning (FC) and examined by immunoblot analysis by probing with antibodies to phospho-JNK, 1312 
JNK, and GAPDH.  The amount of 46-kDa and 54-kDa phospho-JNK was quantitated and normalized to 1313 
the amount of JNK in each sample (mean ± SEM; n=5; ***, p<0.001, for JIP1TA compared with JIP1WT 1314 
mice; #, p<0.01, ##, p<0.001 compared with the naïve control, two-way ANOVA, followed by Bonferroni's 1315 
post-hoc test 1316 
 1317 
 1318 
 1319 
Figure 5.  The threshold for LTP induction is reduced in JIP1TA mice.   1320 
(A,B)  Basal synaptic transmission at Schaffer collateral-CA1 synapses, as assessed by measuring the 1321 
fEPSP input-output relationship (A) and the fEPSP slope to fiber volley relationship (B), was similar in 1322 
JIP1TA slices (n = 16 slices, 13 mice) compared with slices obtained from JIP1WT littermates (n = 16 1323 
slices, 12 mice).  No statistically significant differences were found  (p>0.05, two-way repeated measures 1324 
ANOVA).   1325 
(C)  fEPSPs from JIP1TA (n = 16 slices, 13 mice) and JIP1WT (n = 16 slices, 12 mice) slices exhibited 1326 
similar paired pulse facilitation.  No statistically significant differences were found (p>0.05, two-way 1327 
repeated measures ANOVA).   1328 
(D) High-frequency stimulation LTP was induced by two trains of 100 Hz stimulation (separated by a 20 1329 
sec interval) to the Shaffer collaterals in slices from JIP1TA and JIP1WT mice (n = 10 slices, 8 1330 
mice/genotype).  Stimulation was delivered at time 0 (arrow).  No statistically significant differences were 1331 
found (p>0.05, Student’s t–test).   1332 
(E)  An intermediate-stimulation LTP protocol involved 900 pulses of 10 Hz stimuli delivered at time 0.  1333 
LTP induced at intermediate frequencies was significantly facilitated in slices taken from JIP1TA mice 1334 
when compared to JIP1WT controls n= 10 slices, 9 mice/genotype).  Statistically significant differences are 1335 
indicated (***, p<0.001, Student’s t–test).    1336 
(F)  LTD induced by low-frequency (1 Hz, 900 pulses, 0-15 min time) stimulation was significantly reduced 1337 
in JIP1TA slices compared to JIP1WT slices (n= 10 slices, 10 mice/genotype).  Statistically significant 1338 
differences are indicated (***, p<0.0001, Student’s t–test).   1339 
(G)  LTD induced by 0.5 Hz stimulation (0.5 Hz, 900 pulses, 0-30 min time) was similar in JIP1WT and 1340 
JIP1TA slices (n = 14 slices, 11 mice/genotype).  No statistically significant differences were found 1341 
(p>0.05, Student’s t–test).  1342 
(H)  Frequency-response function in JIP1TA and JIP1WT mice.  The percentage change in synaptic 1343 
strength from baseline in JIP1TA and JIP1WT mice at 50-60 min following stimulation at the indicated 1344 
frequency is presented. Values are mean ± SEM.  Magnitudes of LTP/LTD were calculated as the ratio of 1345 
the average fEPSPs between 50-60 min and average baseline fEPSPs between -20 min -0 min. 1346 
Statistically significant differences are indicated (***, p<0.001, Student’s t–test).    1347 
(I) mGluR-dependent LTP in hippocampal slices from JIP1TA and JIP1WT mice. mGluR-LTD was induced 1348 
by incubation of JIP1TA and JIP1WT slices with DHPG (100 μM) for 5 min (n= 10 slices, 10 mice/genotype). 1349 
Basal fEPSPs were recorded prior to LTD induction with DHPG. No statistically significant differences 1350 
were found (p>0.05, Student’s t–test).   1351 
(J) Depotentiation is not affected in JIP1TA mice. High-frequency stimulation (100 Hz twice for 1 s with 20 1352 
s interval), followed with 1 Hz (15 min) stimulation 10 min later to the Shaffer collaterals produced similar 1353 
depotentiation in slices from JIP1TA and JIP1WT mice (n = 10 slices, 10 mice/genotype).  No statistically 1354 
significant differences were found (p>0.05, Student’s t–test).   1355 
The insets in D-J show representative fEPSP responses obtained before and after LTP, LTD and 1356 
depotentiation inducing stimuli.  (Calibration: 0.2 mV/10 ms). 1357 
 1358 
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 1360 
Figure 6. Inhibition of JNK signaling mimics the effect of JIP1 (Thr103Ala) mutation on NMDA 1361 
receptor-dependent LTD. 1362 
(A, B) JNK-in-8 treatment did not affect baseline synaptic transmission or paired-pulse facilitation in wild-1363 
type slices. Input–output curves, as assessed by the fEPSP slope to fiber volley relationship, were similar 1364 
in vehicle-treated slices (n = 12 slices) compared with wild-type slices treated with JNK-in-8 (n = 12 1365 
slices) (A). fEPSPs from vehicle-treated slices (n = 12 slices) and JNK-in-8 treated (n = 12 slices) slices 1366 
exhibited similar paired pulse facilitation (PPF) (B) (p>0.05, two-way repeated measures ANOVA). 1367 
(C) High-frequency stimulation (HFS)-LTP was induced with a pair of 100 Hz tetani in the presence of 1368 
either vehicle (n = 12) or 6 μM JNK–in-8 (n = 12). LTP was unaffected by JNK inhibition. (p> 0.05, 1369 
Student’s t–test).  1370 
(D) Low-frequency stimulation (LFS)-LTD was induced (1 Hz, 900 pulses) in the presence of either 1371 
vehicle (n = 10) or 6 μM JNK–in-8 (n = 10). LTD was impaired by JNK inhibition (***, p<0.001, Student’s 1372 
t–test). 1373 
The insets in C and D show representative fEPSP responses obtained before and after LTP/LTD inducing 1374 
stimuli. (Calibration: 0.2 mV/10 ms). 1375 
 1376 
 1377 
 1378 
Figure 7.  The JIP1TA mutation promotes increased NMDA receptor expression and activity.  1379 
(A-C)  Lysates prepared from the hippocampi of JIP1TA and JIP1WT mice were examined by immunoblot 1380 
analysis by probing with antibodies to NMDA and AMPA receptor subunits, SAP102, JIP1, and ?-tubulin 1381 
(A).  The amount of NMDA receptor subunits in the hippocampus was quantitated and normalized to the 1382 
amount of ?-tubulin in each sample (B, mean ± SEM, n = 5; **, p<0.01, Student’s t-test).  The amount of 1383 
NMDA receptor subunit mRNA in the hippocampus was measured by quantitative RT-PCR and 1384 
normalized to the amount of Gapdh mRNA in each sample (C, mean ± SEM, n = 5; p>0.05, Student’s t-1385 
test).   1386 
(D)  Enrichment of NMDA receptor subunits in the synaptoneurosome fraction of the hippocampus of 1387 
JIP1WT and JIP1TA mice was examined by immunoblot analysis.   1388 
(E,F)  Primary JIP1WT and JIP1TA hippocampal neurons were fixed and processed for 1389 
immunofluorescence analysis under non-permeabilized (left panels) and permeabilized (right panels) 1390 
conditions.  GluN1 surface and intracellular expression was examined by confocal microscopy (E).  1391 
Quantitation of the cell surface expression of GluN1 in JIP1TA and JIP1WT hippocampal neurons was 1392 
performed using ImageJ software (F).  The data presented are the mean ± SEM; n = 8~10; **, p<0.01, 1393 
Student’s t-test).   1394 
(G)  The expression of  cJun and cFos mRNA in the hippocampus of JIP1WT and JIP1TA mice was 1395 
normalized to the amount of Gapdh in each sample (mean ± SEM, n = 5~6).  Statistically significant 1396 
differences are indicated (**, p<0.01, Student’s t test).   1397 
(H)  Lysates prepared from the hippocampus of JIP1WT and JIP1TA mice were examined by immunoblot 1398 
analysis with antibodies to phospho-ERK, ERK, phospho-CREB, CREB, KIF17, and ?-Tubulin.  The 1399 
amount of phospho-ERK and phospho-CREB was quantitated (mean ± SEM, n = 5).  Statistically 1400 
significant differences are indicated (**, p<0.01, Student’s t-test).  1401 
Figure 8.  Increased synaptic NMDA receptor activity in hippocampal slices from JIP1TA mice.   1402 
(A)  Whole-cell voltage clamp traces depicting typical EPSCs elicited by stimulating the Schaffer 1403 
collaterals while recording CA1 pyramidal cells from JIP1WT and JIP1TA hippocampal slices.  Strong 1404 
blockade of NMDA receptors at a holding potential of -70 mV by magnesium isolates the AMPA 1405 
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component (lower traces).  The +50 mV upper traces primarily represent the NMDA component because 1406 
the traces were recorded 30-50 msec after stimulation when approximately 90% of the AMPA receptor 1407 
response had decayed. The traces show the increase in the NMDA receptor-mediated component for the 1408 
JIP1TA group relative to JIP1WT, while AMPA receptor mediated responses were not different. Traces 1409 
depicted are averages of 20 sweeps for both NMDA and AMPA receptor-mediated components of JIP1WT 1410 
recorded from the same pyramidal neuron; 10 and 15 sweeps were used to produce the averages 1411 
depicted for the NMDA and AMPA receptor-mediated components recorded from a JIP1TA pyramidal 1412 
neuron.   1413 
(B,C)  Comparison of average NMDA and AMPA receptor currents.  NMDA receptor-mediated currents 1414 
(B) were significantly greater in the JIP1TA group in comparison to the JIP1WT group (mean ± SEM; n = 16 1415 
~ 17 cells; *, p<0.05, Student’s t-test) while average AMPA receptor-mediated currents (C) did not differ.   1416 
(D)  NMDA to AMPA receptor current ratios were evaluated on a cell-by-cell basis.  The JIP1TA ratios 1417 
(INMDA / IAMPA) were larger than ratios measured from neurons in the JIP1WT group (mean ± SEM; n = 16 ~ 1418 
17 cells; *, p<0.05, Student’s t-test).   1419 
(E,F)  NMDA-stimulated gene expression in primary cultures of JIP1WT and JIP1TA hippocampal neurons 1420 
was studied by treating neurons with 100 μM NMDA plus 10 μM glycine.  The expression of Bdnf (E) and 1421 
cFos (F) mRNA was quantitated by RT-PCR and normalized to Gapdh (mean ± SEM; n= 5~6; ***, 1422 
p<0.001, two-way ANOVA followed by Bonferroni's post-hoc test).   1423 
 1424 
 1425 
 1426 
Figure 9.  JIP1TA mice display normal locomotor function, motor coordination, elevated anxiety-1427 
like behavior and increased acoustic startle response. 1428 
(A-C)  Elevated Plus Maze. JIP1TA mice show decreased time spent in open arms (A), increased time 1429 
spent in closed arms (B) relative to wild-type mice, indicative of elevated anxiety-like behaviors. In 1430 
addition, JIP1TA mice show normal activity as measured by total distance traveled (C).  The data are 1431 
presented as the mean ± SEM (n = 10; **, p<0.01, Student’s t–test).   1432 
(D,E)  Open Field Test.  JIP1TA mice show increased anxiety-like behavior in an open field test.  Mice 1433 
were allowed to explore an open field for 5 min. JIP1TA mice spent more time in the periphery (D) and less 1434 
time in the center region of the open field (E), both indicators of increased levels of anxiety-like behavior 1435 
in this test.  The data are presented as the mean ± SEM (n = 10; ***, p<0.001, Student’s t–test).   1436 
(F)  JIP1TA mice showed an increased acoustic startle response for the 110 dB acoustic startle stimulus 1437 
compared with JIP1WT mice (mean ± SEM; n = 8; *, p<0.05, two-way repeated measures ANOVA 1438 
followed by Bonferroni's post-hoc comparisons tests).   1439 
(G)  No significant differences in prepulse inhibition for the 74, 80 and 86 dB pre-pulse sound levels 1440 
followed by a 110 dB startle stimulus were observed between JIP1TA and JIP1WT mice  (mean ± SEM; n = 1441 
8; p>0.05, two-way repeated measures ANOVA followed by Bonferroni's post-hoc test.   1442 
(H) JIP1TA mice have normal balance and motor coordination, but impaired skill learning on the rotarod. 1443 
Mice received four trials on day 1 (Trials 1-4) and day 2 (Trials 5-8).  The duration of balance or latency to 1444 
fall (4–40 rpm over 5 min) was recorded. Mice were trained on day 1 to establish baseline performance, 1445 
and retested 24 hours later to measure skill learning. Both JIP1TA and JIP1WT mice exhibited increased 1446 
skill in maintaining balance on the rotarod over the first four trials on day 1. On day 2, JIP1TA mice failed 1447 
to display motor coordination achieved after the day 1, indicative of impaired motor learning in the rotarod 1448 
task.  Data are presented as mean ± SEM; n = 8; *, p<0.05, two-way repeated measures ANOVA 1449 
followed by Bonferroni's post-hoc test. 1450 
 1451 
 1452 
 1453 
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Figure 10.  JIP1TA mice display enhanced contextual fear and impaired fear extinction.  1454 
(A)  “Strong” (0.8 mA electric shock) training demonstrated that JIP1TA and JIP1WT littermate mice 1455 
exhibited similar contextual freezing when tested immediately after training, or 1 h later, but the JIP1TA 1456 
mice froze more than JIP1WT mice at 24 h following training (left panel). Foot-shock reactivity during fear 1457 
conditioning training did not significantly differ between JIP1TA and JIP1WT mice (right panel).  The data 1458 
presented are the mean ± SEM (n = 10 ~ 11; ***, p<0.001, Student’s t-test).   1459 
(B)  “Weak” (0.4 mA electric shock) training demonstrated that JIP1TA mice (n = 14) exhibited contextual 1460 
freezing that was similar to the “strong“ training schedule, but JIP1WT mice (n = 14) displayed significantly 1461 
less contextual fear conditioning at 24 h following training (mean ± SEM; n = 14; ***, p<0.001, Student’s t-1462 
test).   1463 
(C)  JIP1TA and JIP1WT littermate mice were infused with vehicle or the selective NMDA receptor 1464 
antagonist APV (10 μg/ml) before “strong” (0.8 mA) contextual fear conditioning. The following day, there 1465 
was a similar impairment in both genotypes in freezing levels to the conditioning context (mean ± SEM; n 1466 
= 10; ***, p<0.001 vs. JIP1WT+ veh; not significant (ns) JIP1WT+ APV vs. JIP1TA+ APV; two-way ANOVA followed 1467 
by Bonferroni's post-hoc test). 1468 
 1469 
(D) JIP1TA and JIP1WT littermate mice were trained by “strong” (0.8 mA electric shock) contextual fear 1470 
conditioning. Extinction began 24 h later and consisted of daily 3-min re-exposures of mice to the 1471 
conditioning context in the absence of shock. When compared with JIP1WT littermates, JIP1TA mice 1472 
showed increased freezing behavior throughout extinction days 1-7 (E1-E7), indicating impaired 1473 
extinction process in JIP1TA mice (mean ± SEM; n = 10; *, p<0.05, ***, p<0.001; two-way repeated 1474 
measures ANOVA followed by Bonferroni's post-hoc test). 1475 
(E) “Weak” (0.4 mA electric shock; left panel) and “strong” (0.8 mA; right panel) cued fear training, 1476 
consisting of a single pair of cue (tone) and shock, demonstrated that JIP1TA and JIP1WT mice exhibited 1477 
enhanced conditioned freezing to a cue, tone, when tested 24 h following training (mean ± SEM; n = 11; 1478 
*, p<0.05, **, p<0.01, Student’s t-test).   1479 
 1480 
 1481 
 1482 
Figure 11.  JIP1TA mice exhibit enhanced acquisition and reversal learning in the Morris water 1483 
maze test. 1484 
(A-C)  JIP1TA and JIP1WT littermate mice learned the visible platform task (day 1 & 2), as indicated by 1485 
reductions in escape time during training.  The mice were then trained to find a hidden platform during the 1486 
next seven days.  JIP1TA mice showed faster escape latencies at days 6-9 training compared with JIP1WT 1487 
littermates (A).  A first probe test (day 10) was conducted 24 h after the completion of training.  No 1488 
significant differences in percentage time spent in the target quadrant (T) between JIP1TA and JIP1WT 1489 
mice were observed (B).  The mice were then subjected to 2 days of additional training (days 11-12), and 1490 
a second probe trial was performed 24 h later.  No significant differences between JIP1TA and JIP1WT 1491 
mice were observed during second probe trial (C).  Data presented are the mean ± SEM (n = 14; *, 1492 
p<0.05, two-way repeated measures ANOVA, followed by Bonferroni's post-hoc test).   1493 
(D-F) Twenty-four hours after the second probe test, the platform was moved to the opposite quadrant in 1494 
the pool and mice were trained for four trials (day 14, reversal learning).  In this new setting, JIP1TA mice 1495 
displayed shorter escape time to find newly placed platform (NT) compared with JIP1WT littermate mice 1496 
(E).  The probe test for reversal training was conducted 24 h after the completion of new platform training 1497 
(day 15).  Analysis of the time spent in the quadrants revealed that JIP1TA mice spent significantly more 1498 
time in the new target quadrant than JIP1WT mice (F).  Data presented are the mean ± SEM (n = 14; *, 1499 
p<0.05, ***, p<0.001, two-way repeated measures ANOVA (E) and two-way ANOVA (F) followed by 1500 
Bonferroni's post-hoc tests).   1501 
 1502 
 1503 
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Figure 12.  Suppression of kainate-induced JNK activity in the hippocampus of JIP1∆JBD mice.  1506 
(A,B)  A targeting vector was designed to replace JIP1 residues Leu160-Asn161-Leu162 with Gly160-Arg161-1507 
Gly162 in exon 3 of the Jip1 gene by homologous recombination in ES cells. The floxed NeoR cassette 1508 
inserted in intron 3 and used for selection was deleted with Cre recombinase. H, HindIII. 1509 
(C)  Lysates prepared from the cerebral cortex of Jip1+/+ (WT) and Jip1∆JBD/∆JBD (∆JBD) mice were 1510 
examined by immunoblot analysis using antibodies to JIP1 and ?-Tubulin.   1511 
(D,E)  JIP1WT and JIP∆JBD mice were treated without and with kainate.  Representative sections of the 1512 
dentate gyrus stained (green) with antibodies to phospho-cJun (D) or cJun (E) are presented.  DNA was 1513 
stained with DAPI (red).  Scale bar = 75 μm. 1514 
 1515 
 1516 
 1517 
Figure 13.  Disruption of the JNK binding domain (∆JBD) on JIP1 causes enhanced associative 1518 
learning.   1519 
(A)  Contextual and cued fear conditioning of JIP1∆JBD and JIP1WT mice consisted of one exposure to cue 1520 
[context + tone] and 0.8mA shock (mean ± SEM; n = 10~11; **, p<0.01, Student’s t-test ***, p<0.001, 1521 
Student’s t-test).   1522 
(B,C)  Morris water maze tests of mean latencies to escape to a visible (days 1-2) or a hidden platform 1523 
(days 3-12) are presented for JIP1∆JBD or JIP1WT mice (B).  Probe trials were performed on days 9 and 13 1524 
of water maze training (C).  JIP1∆JBD mice spent significantly longer time in the target quadrant compared 1525 
to JIP1WT littermates (mean ± SEM; n = 10; *, p<0.05; **, p<0.01; ***, p<0.001, two-way repeated 1526 
measures ANOVA (B) and two-way ANOVA (C) followed by Bonferroni's post-hoc tests).   1527 
(D)  The water maze platform was moved to the opposite quadrant in the pool and mice were trained for 1528 
four trials (day 14, reversal learning).  The probe test for reversal training was conducted 24 h after the 1529 
completion of new platform training (day 15).  Analysis of the time spent in the quadrants during the probe 1530 
trial revealed that JIP1∆JBD mice spent significantly more time in the new target quadrant (NT) than JIP1WT 1531 
mice (mean ± SEM; n = 10; ***, p<0.001, two-way ANOVA followed by Bonferroni's post-hoc test).   1532 
(E)  Hippocampus lysates of JIP1WT, JIP1TA and JIP1∆JBD mice were examined by immunoblot analysis by 1533 
probing with antibodies to NMDA receptor subunits and ?-Tubulin.   1534 
(F)  The amount of phospho-ERK in hippocampus lysates of naïve JIP1WT and JIP1∆JBD mice was 1535 
quantified by multiplexed ELISA and normalized to the amount of ERK2 in each sample (mean ± SEM; n 1536 
= 5; *, p<0.05, Student’s t-test). 1537 
 1538 
 1539 
 1540 
Figure 14.  A model of how JIP1-mediated JNK signaling regulates synaptic NMDA receptor 1541 
expression. JIP1-dependent JNK activation by the NMDA receptor (NMDAR) may suppress translation 1542 
of NMDA receptor subunit mRNA (Grin1, Grin2a, Grin2b). Alternatively, the same pathway regulates cell 1543 
surface insertion or retrieval of NMDA receptors and/or lateral diffusion of extrasynaptic NMDA receptors 1544 
into synaptic sites.  1545 














